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This study aimed to investigate the impact of several freeze-thaw (F/T) process parameters 
on the quality attributes of a model protein solution, L-lactate dehydrogenase (LDH) in 20 mM 
histidine buffer, through a design of experiments (DoE) approach. We observed variable F/T rates 
and ice front velocities at different regions within 1 L bottles containing the solution. The analysis 
from 46 experimental runs indicated over four-fold increase in the freezing rate at the lower 
freezing temperature (-80 °C, instead of -20 °C), and a two-fold increase in the thawing rate by a 
novel forced air-flow methodology. Greater loading distances among multiple bottles and lower 
fill volumes also resulted in higher F/T rates, which correlated with improved retention of the LDH 
enzymatic activity and native tetramers. 
 Furthermore, novel methodologies were designed to measure both the ice surface area and 
the heterogeneous distribution of solutes at ice-cored samples from different regions of the frozen 
bottles. A homogeneity score was also devised to describe the overall homogeneity of the frozen 
bulk. Freezing at slower rates in 1 L bottles was found to generate extensive solutes (i.e., LDH, 
sucrose, phosphate and histidine buffers) redistribution. Multiple linear regression modeling 
showed that higher freezing rates, samples cored from the center-bottom regions inside the bottles, 
and presence of sucrose all have significant positive impact on LDH stability.  
Bruna C. Minatovicz, University of Connecticut, 2019 
 
 
The residence time of the protein in the low-viscosity fluid state after ice formation was 
implicated as the predominant factor in the LDH destabilization during large-scale F/T process. 
The faster freezing process limited the residence time and, thus, the protein susceptibility to both 
the redistribution of solutes upon freezing and ice-aqueous interfaces. 
Additionally, a new scale-down method was thoroughly evaluated for uncontrolled F/T of 
LDH solutions. Equivalency of product temperature-time profile was demonstrated at several 
positions inside both 500 mL and 5 L containers; not only at the last point to freeze-or-thaw. The 
small-scale model successfully reproduced the impact of the large-scale F/T process on LDH 
activity, LDH tetramers, and formation of subvisible particles. Moreover, the magnitude of 
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In the late 1970s and early 1980s, the biotechnology industry began to develop its first 
biologics for use as human therapeutic agents, such as recombinant proteins and monoclonal 
antibodies. As of August 2019, more than 385 biologics have been approved by the U.S. Food and 
Drug Administration 1. Proteins possess complex physical and chemical properties that render 
significant stability challenges. Freezing is the process of choice to stabilize many biologics during 
storage and transportation, but it has its limitations. While often more stable in the solid state, 
certain proteins might suffer irreversible structural damage during the process of freeze-thaw 
which results in partial or total loss of therapeutic activity. Ideally, a combination of process 
control and formulation optimization can be employed to maintain purity, activity, and efficacy of 
proteins subject to freeze-thaw. 
Freeze-thaw of protein solutions is routinely employed during biopharmaceutical 
development and production. This process offers operational flexibility for the drug product fill 
and finish while extending its shelf life 2,3. When proteins are stored in the frozen state, the rates 
of many reactions leading to physical and chemical degradation are decelerated 4. Freezing of 
protein solutions minimizes the possibility of microbial growth and eliminates mechanical stress 
and foaming during transportation 5.  
However, despite several advantages over liquid storage, destabilizing stresses arising 
during freezing can lead to the perturbation of the native protein chemical, secondary, and higher 
order structures necessary for biological activity 6. Physical and chemical denaturation often result 
in protein aggregation 7 that not only can impair the activity of the drug but can also induce 
immunogenic responses 8. These stressful conditions include protein adsorption to ice-aqueous 




During freezing of protein solutions, as ice nucleates and crystallizes out of the solution, the 
remaining unfrozen solution experiences an increase in the concentration of solutes, a process 
termed amorphous phase freeze-concentration 10. The main focus of this dissertation, however, is 
on a second classification of freeze-concentration, known as macroscopic freeze-concentration 10. 
On a macroscopic scale (centimeter scale), solutes are progressively pushed into a certain direction 
by the growing ice front resulting in the redistribution of the solutes throughout the frozen bulk 11.  
The redistribution of solutes has been recognized as an important stress fostering protein 
degradation during freezing 12,13. Another stress commonly related to irreversible protein 
denaturation is protein adsorption at ice-aqueous interfaces 14. Importantly, one of the determining 
factors for both macroscopic freeze-concentration and the extent of ice-aqueous interfaces is the 
rate of freezing, which depends on the volume-scale being processed.  
 
1.2 Objective 
The freeze-thaw process is not yet fully understood, especially at large-scale 15. The majority 
of published studies on freeze-thaw of therapeutic proteins were conducted on small solution 
volumes (e.g.,  2–4 mL) 14,16-18, which are not capable of revealing the formation of temperature 
and solute concentration gradients that occur during large-scale freezing and are best studied at 
larger volumes (i.e., ≥ 1 L) 19. On the other hand, there is also a growing interest in the 
pharmaceutical industry to develop small-scale models to study the potential impact of process 
variables on protein stability during large-scale freeze-thaw. Hence, the overall goal of this 
dissertation research was to investigate the fundamental mechanisms and the impact of freeze-thaw 
process parameters on the stability of a model protein, lactate dehydrogenase (LDH), under large-




1. To elucidate the impact of freeze-thaw rates on LDH stability in large containers. 
2. To mechanistically understand the contribution of freezing-induced stresses to the LDH 
denaturation upon large-scale freezing. 
3. To develop a scale-down model for large-scale uncontrolled freeze-thaw process of protein 
solutions.  
 
1.3 Organization of Chapters 
Chapter 2 provides a general overview of the freeze-thaw unit operation applied to large-volumes 
of protein solutions. The use of a design of experiments approach to study several freeze-thaw 
process parameters is discussed. Furthermore, multivariate linear regression models were 
developed to provide a thorough understanding of the freeze-thaw process at 1 L scale and to 
identify critical process parameters. This chapter reveals the impact of the freeze-thaw conditions 
to the quality attributes of LDH. Particularly, it confirms the feasibility of using a faster freezing 
and forced air-flow thawing procedure to maintain the stability of LDH solutions during bulk 
freeze-thaw unit operations. 
 
Chapter 3 builds upon the findings from Chapter 2 and focus on the F/T conditions which resulted 
in the best- and worst-protein stability based on the 46 F/T runs previously performed. This chapter 
discusses the underlying stabilization mechanisms and the relative contributions of the ice surface 
area, extent of freeze-concentration of the solutes, and time, to the LDH instability post F/T cycles. 
 
Overall, the extent of solutes redistribution upon freezing can be directly correlated to the solution 
volume 21. As a result, solutes redistribution becomes an important factor governing protein quality 




measure the spatial 3D distribution of solutes and to quantify protein quality attributes at different 
regions in the frozen volume. This study reveals the impact of the freezing rate, extent of 
heterogeneous distribution of LDH and several excipients, and position of ice-cored samples 
within 1 L bottles on LDH degradation. 
 
Manufacturing-scale F/T studies demand huge quantities of the drug substance, which is usually 
limited during the early stages of drug development. Besides, large-scale tests are expensive, time-
consuming, and can delay time-to-market 23. Thus, Chapter 5 describes the development of a new 
scale-down method for large-scale uncontrolled freeze-thaw of protein solutions in plastic bottles. 
In commercially available plastic containers, however, the heat transfer path length changes as the 
bottle dimensions are altered with the scale and the freeze-thaw process is not amenable to linear 
scale-up. Thus, the evaluation of a stepwise program using a controlled-temperature chamber is 
presented for its ability to result in superimposable product temperature profiles between a 500 
mL and 5 L scales. This chapter also discusses the F/T process using 500 mL to reproduce 5 L in 
terms of the protein quality attributes and freezing-induced stresses. 
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Use of a Design of Experiments (DoE) Approach to Optimize Large-Scale 











Storage and shipment of large volumes of protein solutions typically occur in the frozen 
state. However, inappropriate freeze-thaw (F/T) processes can lead to protein instability and loss 
of high-value drug products. This study, therefore, aimed to determine the impact of several F/T 
process parameters on lactate dehydrogenase (LDH) quality attributes. A response surface model 
was designed to evaluate the following main factors: fill volume in 1 L polycarbonate containers, 
loading distance among nine containers during F/T, freezer set temperature, and a novel forced-air 
flow methodology during thawing. The analysis from 46 experimental runs indicated significant 
higher F/T rates after increasing the distance among the containers from 1 cm to 5 or 10 cm and 
lowering the solution fill volume from 90% to 70% or 50% (v/v). Over 4-fold increase in the 
freezing rate was found when the set freezer temperature was lowered from -20 °C to -80 °C. 
Furthermore, the forced-air flow at 98 fpm doubled the thawing rate.  
Before and after the F/T runs, the LDH quality attributes were assessed by both LDH 
enzymatic activity bioassay and size exclusion chromatography to track the loss of LDH native 
tetramers. Multivariate linear regression modeling showed that all main factors investigated have 
significant impact on LDH stability. The factor that most strongly affected the retention of LDH 
activity was the loading distance:  ≥ 5 cm among containers positively affected the LDH activity 
response in 50.6%. The factor that most strongly retained the LDH tetramers was the set freezer 
temperature towards the lower range of -80 °C (2.2% higher tetramers retention compared to -20 
°C freezing). Moreover, parameters of both freezing and thawing steps had comparable effect on 
LDH quality attributes.  
In summary, this DoE-based systematic analysis increased F/T process understanding at 




faster freezing and forced-air thawing procedures to maintain the stability of LDH solutions during 
large-scale F/T unit operations.  
 
2.2 KEYWORDS: freeze-thaw, design of experiments, protein quality attributes 
 
2.3 INTRODUCTION 
Storage and shipment of bulk volumes of protein solutions can occur in the liquid state, as 
a dry powder, or in a frozen form. The solid-state options are often preferred due to the technical 
challenges associated with liquid storage and shipment. Frozen storage increases protein solution 
stability, extends the drug product shelf life, offers flexibility during manufacturing, mitigates the 
risk of microbial growth, and eliminates agitation and foaming during transportation 1–3. Thus, 
freezing and subsequent thawing (F/T) are integral steps in the manufacturing of most 
biopharmaceutical products 4.  
Despite the several advantages conferred by frozen storage of biologics, non-optimal F/T 
processes can lead to protein instability and substantial loss of high-value drug products. It is 
important to ensure that the protein retains its biological activity and native state throughout 
manufacturing, distribution, and shelf life of the drug product. In this sense, non-native protein 
aggregates in the drug substance storage phase should be well controlled; as even small levels of 
aggregates can serve as nuclei for the formation of visible and subvisible particles when the 
solution is further exposed to fill and finish processing stresses 4. 
It has also been recognized that small-scale F/T process studies have limited scalability to 
the large-scale operation, because of the remarkable difference in heat exchange areas and the 




understood regarding the main influencing factors, and most of F/T general guidelines are stated 
for small-scale processing. Therefore, this study aims to characterize the F/T process at a relevant 
industrial scale (1 L scale) and to investigate the impact of several process variables on protein 
stability. 
As exemplified in Figure 1, numerous variables can influence the quality attributes of 
protein solutions subjected to F/T processing and the transportation and storage between freezing 
and thawing. F/T can be performed applying both controlled and uncontrolled rate F/T technology. 
One of the main advantages of controlled rate F/T systems is the high degree of uniformity and 
process reproducibility. These systems were designed to provide a large heat-transfer surface to 
volume ratio, which can accelerate the overall process and mitigate the effects of solutes 
macroscopic freeze-concentration. CryoVessels® utilize stainless-steel vessels to F/T large 
volumes of drug substance (125 to 300 L). However, these systems are capital intensive and large 
walk-in freezer rooms are required to store the frozen vessels 4,10. Additional operational 
challenges may arise after repeated F/T cycles due to surface modification of the stainless-steel 
vessels and increased levels of iron and other metals leaching into the protein solution 10. An 
alternative type of controlled F/T system is the Celsius® CFT, which utilizes ethylene vinyl acetate 
(EVA) Celsius® bags containing up to 16.6 L of solution. These bags are compressed between 
two heat exchange plates through which a silicone-based heat transfer fluid is circulated 4. The 
frozen EVA film has a brittleness temperature in the range of -70 °C to -76 °C; thus, there is a 
concern regarding its fragility during shipment and storage.  The Celsius® CFT system is also 
expensive and requires up-front investiment, but the disposable EVA bags have the advantage of 
being sterile, single-use containers that can be stored in either standard freezers or walk-in freezer 




Uncontrolled freezing is usually achieved by ultra-low-temperature freezers, bath of dry 
ice/ethanol or liquid nitrogen 9. Apart from the plastic bags and stainless-steel vessels utilized for 
controlled F/T, single-use plastic containers between 1-20 L represent an attractive option for 
uncontrolled F/T of drug substances. For frozen storage and shipment, polycarbonate bottles are 
preferred over most of the other types of plastic materials because of their ability to withstand both 
freezing and autoclaving conditions and rigorous shipping and handling. Polycarbonate plastic 
containers have low glass transition temperatures and brittleness temperatures, remaining rubbery 
until −135 °C 9,11. One of the biggest challenges with uncontrolled F/T rate technology, however, 
is the lack of inter-batch consistency. The variations arise from the design of the freezers, cooling 
capabilities of the refrigeration system, and location of the containers within the freezer. Notably, 
the thermal loading and distance among multiple containers are usually overlooked during 
uncontrolled F/T process development.  
Drug substances are routinely frozen at temperatures ranging from -20 °C to -80 °C 9. 
Generally, it is advisable to store the product below the glass transition temperature of the 
maximum freeze concentrate (Tg’) to ensure complete conversion of the free water into ice, which 
minimizes mobility-driven reactions 4.  
Similarly, several methodologies can be applied for the thawing processes. Particularities 
of the thawing process include its dynamic nature (shakers or roller racks can be used) and 
associated solution hold-times. Applying agitation may help with solution homogenization and 
can accelerate the process; on the other hand, substantial ice-liquid and air-liquid interfaces can be 
generated, which fosters protein denaturation. Also, once thawing is complete, solutions may begin 
to warm as energy is continuously delivered to the solution. Therefore, the end-point for thawing 




Freeze-thaw behavior of proteins has been extensively investigated but primarily in small 
volumes (a few mL of solution) and often associated with lyophilization. Freeze-thaw studies 
conducted with low solution volumes are not capable of providing a valid representation of the 
process at larger volumes (i.e., ≥ 1 L), because of the differences in heat and mass transfer 
dimensions 12. The current study evaluates the impact of several F/T process parameters on the 
quality attributes of a model protein solution, L-lactate dehydrogenase (LDH), in 1 L bottles. F/T 
parameters which have been previously correlated to protein stability were selected for this study: 
thermal loading and distance among multiple containers, fill volume, freezer set temperature above 
and below Tg’ 1,13,14, and a novel forced-air method designed to accelerate thawing.  
 
2.4 MATERIALS AND METHODS 
2.4.1 Materials 
L-Lactate dehydrogenase (LDH) from rabbit muscle in ammonium sulfate suspension was 
purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). L-histidine monohydrochloride 
monohydrate and L-histidine were obtained from VWR International (Philadelphia, PA, USA). 
 
2.4.2 Solution preparation  
LDH suspension was dialyzed against 20 mM histidine buffer, pH 7.0, with a 3.5 K MWCO 
membrane at 4°C for two hours twice followed by an overnight buffer exchange before use. The 
concentration of LDH was determined from UV absorbance (extinction coefficient 1.44 mL.mg-
1.cm-1 at 280 nm) 15. The protein solution after dialysis was filtered (0.22 µm syringe filter) and 





2.4.3 Freeze-thaw cycles 
To investigate the effect of F/T process parameters on LDH stability in 1 L square 
polycarbonate containers, a response surface model (main factors, second-order interactions, 
quadratic effects, five center points, and two replicates for each run) and additional full factorial 
runs were designed and the results of 46 F/T runs were evaluated using JMP® 14 software (SAS 
Institute, Cary, NC) (Table 1). The following process parameters were studied: solution fill volume 
(50%, 70%, and 90%), F/T loading configuration (a single bottle or full loading consisting of nine 
bottles arranged in a 3x3 array), loading distance among containers (1 cm, 5 cm, and 10 cm), 
freezing temperature (-20 °C, -30 °C, -50 °C, and -80 °C), and the thawing method (with or without 
forced air flow). The protein solution was frozen in upright stagnant-air freezers (Barnstead lab 
line -20 °C freezer; 10834-034 VWR -30 °C freezer; TSX60086D Thermo Fisher Scientific -50 
°C to -80 °C freezer). After 24 hours of freezing, the bottles were thawed on top of a wired shelf 
placed inside a laminar flow hood at room temperature. The solutions were allowed to thaw until 
at the liquid surrounding the tip of a geometrical centered thermocouple achieved 18 °C. 
Immediately after thawing, a sample withdrawn from the homogenized bulk was analyzed for 
LDH enzymatic activity and loss of LDH tetramers.   
 
2.4.4 Assessment of LDH quality attributes  
Post each freeze-thaw cycle, 20 inversions gently homogenized the bottle contents. A 
representative sample was withdrawn from the bulk and filtered through a 0.22 µm filter. The 





The protein concentration was determined from the absorbance at 595 nm applying a 
Bradford assay 16 (Coomassie Plus Bradford Assay Kit 23236, Thermo Scientific, Rockford, lL 
USA). 
The enzymatic activity of LDH was determined using a LDH activity kit (Sigma-Aldrich 
Co., USA), where LDH catalyzes the reduction of NAD to NADH, which is detected by a 
colorimetric (450 nm) assay. The LDH activity was determined in triplicates, normalized by the 
LDH concentration in each sample and expressed as the remaining percentage of activity relative 
to the initial values before freezing.  
Size exclusion chromatography (SEC) was used to determine the extent of LDH tetramer 
recovery post-F/T process. Analyses were performed on an 1100 Agilent HPLC system coupled 
with Chemstation software®. Samples were separated on an SEC column 
(TSKgel™G3000SWXL, 7.8 mm 30 cm, 5 µm; Tosoh Bioscience, San Francisco, CA) maintained 
at 25 °C. The mobile phase was 100 mM phosphate buffer with 0.2 M NaCl (pH 7.0) delivered at 
1.0 mL/min. Elution was recorded on a diode array UV detector, and calculations were performed 
based on 220 nm chromatograms. The results are reported as the loss percent of LDH tetramer 
contents relative to the initial values before F/T.  
 
2.4.5 F/T time and apparent freezing front velocity 
The center bottle at the full loading configuration contained the protein solution; all other 
containers in the 3x3 array were filled with a thermal surrogate (buffer only). The bottles 
containing the protein solution were frozen with six type T thermocouples placed at different 
locations to monitor temperature changes during F/T. Three sensors were fixed next to the 




thermocouples were placed at the radial center of the bottle, again at the top, middle, and bottom 
locations. All temperature profiles were recorded with a data logger (MicroDaq, SD-947-KIT, 
Contoocook, NH, USA) hooked with the thermocouples.  
The freezing time at each monitored location was defined as the period elapsed from the 
beginning of the freezing process to when the temperature decreased to -20 °C. The thawing time 
was defined as the period from the lowest temperature until the temperature rose to 18 °C at the 
geometrical centered thermocouple. The apparent freezing front velocity was calculated by the 
distance the ice front traveled between two thermocouples over the phase transition time (the time 
at which the solution temperature decreased 0.5 °C below the plateau freezing temperature) 17. 
This ratio of the distance over time was calculated from the edge to center regions at three different 
heights of the bulk (top, middle, and bottom) and from the center bottom to the center middle 
region. The distance applied into the calculations was the half-width of the bottle (4.0 cm from 
edge to center positions), and the distance from the center bottom to the center middle 
thermocouples (3.75 cm at 70% fill). 
 
2.4.6 Statistical evaluation of the results 
JMP® 14.0 was used for statistical assessment of the data. A significance level of 0.05 was 
applied throughout the analysis. Using linear least squares regression, the LDH quality attributes 
were modeled against the main effects of loading distance, fill volume, freezing temperature, 
thawing method, and their two- and three-way interactions. Quadratic terms for the loading 
distance, fill volume, and freezing temperature factors were also included in the models. Outlier 
analysis was performed on the initial model using a studentized residuals test with a threshold of 





2.5.1 Apparent direction and magnitude of the freezing front velocity 
Freezing of large volumes of solutions poses a risk to proteins stability because of the 
potential heterogeneity in solutes distribution within the frozen state, which is fostered by 
temperature gradients within the solution and amplified by longer solidification time. 
Thermocouples positioned at six representative locations within 1 L polycarbonate bottles 
recorded the temperature profiles. The representative thermocouple data from one bottle in Figure 
2 show that the temperature evolution during F/T differ by location within the container.  
The rate of temperature change was quite variable at different thermocouple positions. The 
distance from the edge of the container to its center had a major impact on the F/T temperature 
profiles. Figure 2 shows that freezing completed first at all edge positions, before the ice front 
advanced towards the center bottom, followed by the center top and center middle positions. 
Readouts from the thermocouple placed at the center middle of the solution indicated substantially 
longer F/T times compared to the solution around thermocouples placed near the surfaces of the 
bottle. The center middle (geometrical center) was the last-point-to-freeze as well as the last-point-
to-thaw of the solution. Thus, the temperature change measured at the center middle position was 
chosen for further calculations on F/T rates.  
As the ice front reaches the thermocouples at various locations within the bottle, the 
temperature decreases below the plateau temperature, because the ice is cooled below the freezing 
temperature. Figure 3 shows the apparent velocity of the advancing ice front towards the center of 
the container. The ice front velocity was calculated for the full loading configuration (nine bottles), 
at 5 cm, and 70% fill, as described in section 2.4.5. Within each bottle, the time at which the 




velocity of the moving ice front was slightly higher at the bottom (EB to CB), followed by the 
velocity at the top (ET to CT) and middle regions (EM to CM) inside the container. Towards the 
end of freezing, a fast bottom-up freezing front (CB to CM) was also observed, because of the 
contribution of the freezer cold shelf to an additional axial freezing front. Moreover, the lengthened 
freezing protocol in the -20 °C freezer resulted in an averaged ice front velocity of 2.78 µm/s, 
compared to the 6.11 µm/s at the -80 °C freezer. Lower ambient temperatures can enhance the heat 
flux at the outer plastic surface, which then resulted in the fastest ice front velocities observed 
during freezing at -80 °C. 
 
2.5.2 Effect of the process parameters on F/T rates  
Optimal design of experiments (DoE) is a cost-effective experimentation strategy to 
provide process and product understanding. As emphasized by ICH Q8 6 and the lifecycle 
approach to process validation, introduced by FDA’s 2011 guidance for industry 7, this 
understanding is pivotal to develop, validate, and monitor pharmaceutical processes successfully. 
Thus, 46 DoE-based F/T runs were performed to understand the multifactor effects of the process 
parameters described in Table 1 (loading distance among multiple containers, fill volume, freezing 
temperature, and thawing method) on LDH stability and thereby identify optimal F/T process and 
ensure process robustness 8. 
The impact of the several F/T parameters was first examined for their contribution to the 
overall rates of the processes (Figures 4 and 5). The data on F/T rates were analyzed by one-way 
analysis of variance (ANOVA) and a Tukey-Kramer test. The means of different groups were 
compared at a significance level of 0.05. Increasing the loading distance from 1 cm to 10 cm, or 




freezing rates were also observed at the single loading condition (30 cm). However, the difference 
in the freezing rates observed between 1 cm and 5 cm loading distances were not statistically 
significant. Moreover, the freezing rate increased as the fill volume was reduced from 90% to 
either 70% or 50% of the 1 L bottle, and increased over 4-fold as the freezer temperature was 
lowered from -20 °C to -80 °C. Similarly, significant higher thawing rates were achieved by 
increasing the loading distance from 1 cm to either 5 cm or 10 cm among the containers and 
reducing the fill volume from 90% to either 70% or 50%. Faster thawing was achieved by a 
constant air-flow at 98 fpm passing through the bottles. Such process condition doubled the 
thawing rate, from 0.045 to 0.089 °C/min. Also, the forced-air flow during thawing doubled the 
thawing rate. 
 
2.5.3 Effect of F/T process parameters on LDH quality attributes 
Robust F/T processes are essential for manufacturing and storage of stable 
biopharmaceutical drug products. The loss of both LDH native tetramers and enzymatic activity 
was assessed for different F/T processing conditions, as indication for LDH degradation during 
F/T. 
The retention of LDH activity post-F/T varied broadly between 34 and 100% of the initial 
value before freezing, as shown in Figure 6. Higher LDH activity was maintained post-freezing at 
-80 °C (89 ± 11 %, average and standard deviation of six runs), compared to the average LDH 
activity post -20 °C freezing of 68 ± 21%. The observed LDH activity was also higher for the F/T 
cycles performed at lower fill volumes of 50% and 70%, compared to the 90% fill volume. 
Higher average LDH activity was retained for the solutions thawed with the forced air-




It has been previously demonstrated that certain conditions in the frozen state can promote 
the dissociation of the native LDH tetrameric protein 18. The dissociated dimers or monomers are 
more susceptible to aggregate and form high molecular weight species, compared to the LDH in 
its native quaternary structure. Furthermore, Bhatnagar et al. 19 reported the reassociation from 
LDH dimer to tetramer occurring during freeze-concentration at -5 °C, and progressive 
dissociation back to low molecular weight species during thawing. In the present study, the time 
to perform measurements after thawing was kept constant, with the loss of LDH tetramers being 
analyzed immediately after the F/T cycle, as demonstrated in Figure 7. 
The % loss of tetramers was more prominent post -20 °C freezing at 90% fill volume, and 
no forced air-flow during thawing (2.8%). The recovery of LDH tetramers progressively improved 
as freezing was performed at lower temperatures followed by faster thawing (forced air-flow). For 
instance, loss of tetramers was not detected post -80 °C freezing at 50% or 70% fill volume and 
faster thawing. 
The loss of LDH enzymatic activity post-F/T was previously reported to correlate well with 
the dissociation process from the native LDH tetramer to the lower molecular weight subunits 20. 
A good correlation (R2 = 0.75, n = 46) was observed between the loss of LDH tetramers measured 
by SEC and LDH activity (Figure 8) in this study as well. 
 
2.5.3.1 Multifactor model building and maximization of CQAs desirability 
Multivariate linear regression models were built to estimate linear and quadratic effects 
and two and three-way interactions of the F/T process parameters on LDH quality. Both % initial 
LDH activity and % loss of LDH tetramers were modeled against the full factorial of fill volume, 




LDH activity was statistically significant (p<0.0001) with R2 equal to 0.88 and RMSE of 5.00. 
The constructed model for the % loss tetramer was also statistically significant (p<0.0001) with 
R2 equal to 0.95 and RMSE of 0.15. Table 2 shows all statistically significant model factors 
(p<0.05) and their corresponding effect size on both % initial activity and % loss of tetramers.  
All main model factors investigated were found to affect the % initial LDH activity and % 
loss of tetramers in a manner that is significant both statistically (p<0.05) and in magnitude (>25%, 
activity; >1.1% loss of tetramers). Increasing the distance among the bottles showed the highest 
effect size favoring maximum LDH activity post-F/T, followed by the forced air-flow during 
thawing, lower freezing temperature, and lower fill volume conditions. The same main factors had 
the largest effect sizes for the % loss of tetramers, with freezing temperature contributing the most 
to the response variability.  
The model profiler (Figure 9) shows a similar trend concerning the influence of the main 
factors and their associated confidence intervals to the respective model response. The maximal 
LDH enzymatic activity and minimal loss of LDH tetramers were both predicted for F/T runs 
performed at lower freezing temperatures (-80°C or -50°C compared to 24 hours freezing at -
20°C), lower fill volumes of the LDH solution inside the 1 L containers (50% or 70% fill compared 
to 90%), greater loading distances (nine containers at 5 cm to 10 cm apart from each other, 
compared to the 1 cm), and forced air-flow during thawing (50 % faster thawing rate compared to 
the no forced air-flow condition). 
To advance process understanding, it is beneficial to visualize the interactions of the main 
factors. Interaction profilers are recommended per the International Council for Harmonization 
(ICH) Q8 Appendix B 6 to identify interactions for each response and multiple factor combinations. 




Under the concept of quality by design (QbD), the first step into pharmaceutical 
development is to define the desired product performance and identify critical quality attributes 
(CQAs). The manufacturing processes are then developed to meet those product attributes. For 
greater and more in-depth understanding of the process design space, QbD emphasizes the 
importance of identifying the critical process parameters (CPPs), which must be controlled to 
achieve the drug product CQAs. This leads to understanding the impact of process parameters on 
the CQAs and identification and control of sources of variability 8. Nevertheless, CPPs can be 
determined by dividing the effect size by the tolerance (two-sided limits), margin (one-sided limit) 
or mean (no specification limits) of the respective factor. Usually, if the resulting ratio is more 
than 20%, it is critical and may result in out-of-specification events if not controlled 21. 
The multi-factor modeling data were leveraged to guide process optimization and the 
selection of process set points. Based on the prediction profilers and the model equations, 5000 
runs were simulated for each response, out of which, 592 runs were identified with the highest 
desirability for LDH activity (LDH activity > 99.5%), and 498 runs were identified with the highest 
desirability for % loss of tetramers (loss of tetramers < 0.2%). From these runs with maximum 
desirability, we calculated the mean and standard deviation of the main process factors (Table 3). 
The freezing temperature, fill volume, loading distance, and thawing method were identified as 
the CPPs, which, together with the acceptable operating ranges, defined the design space. The 
design space for the uncontrolled F/T of 10 µg/mL LDH in 20 mM histidine buffer, pH 7.0, in 1 L 
bottles comprises of (a) freezing temperature between -60 °C to -76 °C, (b) solution fill volume 
from 65% to 82%, (c) distance of 7.6 cm to 9.5 cm among nine bottles in a 3x3 array (d) forced 





2.5.4 Role of freezing rate and temperature during frozen storage in LDH destabilization  
From the F/T DoE investigation described above, we found that lower temperature during 
freezing correlated well with higher retention of both LDH activity and LDH tetramers. However, 
changing the final freezing temperature using different units of uncontrolled stagnant-air freezers 
(e.g., -20 °C and -80 °C freezers) not only implies in distinct final set temperatures but also in 
different rates of the freezing process. The refrigeration cooling capability of a freezer designed to 
cool to as low as -80 °C is typically different from another one designed to cool to a distinct final 
temperature. The individual contribution of these two confounding factors (i.e., temperature and 
rate) to the overall protein stability after F/T could not be resolved in the DoE study.  
Thus, an additional study was done to establish the effect of both freezing rate and final 
storage temperature on LDH stability. The 24-hour freezing process was compared to 30 days 
frozen storage, for bottles frozen at distinct rates to either -20 °C or -80 °C storage temperature 
(Figure 12). At a fixed freezing rate, lowering the final storage temperature to -80 °C slightly 
improved the retention of both LDH activity and LDH tetramers. However, the most remarkable 
improvement of the LDH quality attributes was observed after a frozen storage initiated by a rapid 
freezing rate of 0.2 °C/min (the average activity was approximately 100% and the average loss of 
tetramers was approximately 0.05%), compared to 0.05 °C/min rate (average activity was 
approximately 78% and the average loss of tetramers was approximately 0.5%), regardless of the 
freezing temperature. 
 
2.5.5 Role of thawing methodology in the destabilization of LDH 
Another finding from the F/T DoE studies was an improved retention of the LDH quality 




present study, the thawing process can be expedited by exposing the bottle contents to elevated 
ambient temperatures or by selecting alternative end-points for the process; all of it may 
compromise protein stability. The impact of several thawing conditions on LDH quality attributes 
were also evaluated, at a fixed freezing condition (Figure 13). The bottle contents thawed with or 
without a forced air-flow, at either room temperature or inside a cold room, and to alternatives 
end-points, such as the 18 °C reading at the geometrical centered thermocouple placed in the 
solution or visual detection of no ice.  
A solution temperature of 7 °C was the highest recorded at the point when no ice was 
visually detected. The no-visible ice end-point took 10.5 h to achieve at room temperature without 
forced air-flow, and 6.8 h with a forced air-flow. On the other hand, a substantial longer time of 
13.5 h was necessary to reach the 18 °C end-point, for the bottle thawed at room temperature and 
no forced air-flow. Regardless of the air-flow condition, faster thawing at room temperature and 
no ice conditions correlated well with the best retention of both LDH activity (from 92% to 105%) 
and LDH tetramers (approximately 0.02% loss of tetramers) post-F/T, whereas thawing performed 
at the cold room and no-visible ice end-point (at about 4 °C for 46 h) resulted in the worst retention 
of both LDH activity (82%) and LDH tetramers (0.23%). 
 
2.6 DISCUSSION 
2.6.1 Effect of the processing conditions on F/T rates  
Large-scale processing is commonly associated with longer freezing times. Besides, 
different regions within a large container will typically be at varying distances from the active 
cooling/heating container walls. These highly variable F/T pathlengths seem to be a major factor 




pathlengths increased the freezing times by 10-fold and the thawing times by 20-fold. In our study, 
the rate of F/T varied according to the radial distance from the walls of the 1 L bottles. Ice 
nucleation and growth started at edge positions, closer to the container walls (Figure 2). The ice 
front then traveled towards the geometrical center of the solution, which was the last point to 
freeze. Moreover, the velocity of the freezing front was higher at the bottom compared to the top 
layers of the solution (Figure 3). These variable freezing rates and ice front velocities at different 
regions within the bottles can contribute to the redistribution of solutes and substantial 
heterogeneity in the composition of the frozen bulk, which can foster protein destabilization 12.  
A faster moving ice front can mitigate the redistribution of solutes during freezing; not 
only because it limits the time for the transport of the solutes towards the last regions to freeze, but 
it can also favor the formation of ice dendrites. Dendrites are ice protuberances formed as a result 
of an undercooled liquid layer immediately ahead of the ice front interface. Langer 24 explained 
dendritic solidification in terms of the incomplete dissipation of the latent heat away from the 
solid-liquid interface upon crystallization. The latent heat is more efficiently dissipated at the 
curved crystal tips than in the hollow regions between tips. Thus, crystallization accelerates at the 
tip, propagating directional crystal growth. Ice dendrites are thought to be highly desirable to 
improve protein stability, because it can inhibit natural convection currents and the diffusion of 
solutes, resulting in a more homogeneous distribution of the solutes within the frozen bulk 26. 
Butler 25 reported that the freezing front for BSA and sucrose solutions was planar for velocities 
slower than 2 µm/s, and above this value, dendritic ice structures were developed. According to 
Figure 3, the solutions frozen at -50 °C and -80 °C showed higher ice front velocities (above 2 
µm/s in all regions analyzed within the containers), and dendrites were possibly present.  




eutectic or glassy solid; conversely, the rate of thawing describes the time required for a frozen 
solution to melt and transition into a liquid 12. Based on the results shown in Figures 4 and 5, higher 
F/T rates were observed at greater loading distances among multiple containers and lower fill 
volumes. The lower freezer temperature also correlated with a higher freezing rate. The novel 
forced air-flow methodology doubled the rate of thawing. 
The fill volume can affect the performance of the F/T process. Lowering the solution fill 
volume reduces the total thermal loading. The heat of fusion depends on the amount of material; 
thus, the phase transition tends to be faster and to require less energy for reduced thermal loadings. 
Also, the fill volume can impair the integrity of the container if the volume expansion upon ice 
formation exceeds the tensile strength of the bottle. On the contrary, under-filled containers are 
more susceptible to implosions because of pressure differentials arising from differences in 
atmospheric pressures and temperatures encountered during F/T or transportation. All these fill-
volume-related contributions need to be factored in during the evaluation and determination of 
minimum and maximum working volumes.  
It is important to characterize the F/T process with respect to the loading parameters. The 
air circulation pattern may be altered by the number and positioning of bottles placed in a freezer, 
and the containers can shield one another to also alter the pattern of radiative heat transfer from 
the freezer walls. Also, maintaining a reasonable separation distance among several containers 
undergoing F/T help to enhance convection of the cold/warm air around the bottles, which leads 
to efficient heat transfer and faster processes. 
The limitations in heat transfer resulting in freeze-concentration in large-scale F/T systems 
arise mostly from their inability to quickly remove the heat of fusion and cool the system as the 




heat conduction. One way to address this problem is to increase the temperature differential 
between the freezer chamber and the solution. Freezing at lower temperatures ensures efficient 
heat transfer by increasing the gradient in temperature driving the heat exchange. Similarly, 
applying forced air-flow during thawing can ensure appropriate dissipation of the cooled air 
surrounding the bottles, resulting in greater temperature gradients and superior heat transfer.  
In addition, the use of containers with high surface area to volume ratio can amplify heat 
transfer rates during both F/T processes. Although 1 L bottles were used in this study, larger 
containers of up to 300 L are of interest on an industrial scale 27. In such cases, alternative designs 
with internal cooling surfaces are utilized to decrease the heat and mass transfer dimensions 
effectively. Fins and baffles are also used within larger tanks to reduce natural convection and 
diffusion of solutes.  
 
2.6.2 Effect of processing conditions on protein stability 
Process characterization and understanding are essential to support efficient drug product 
development and submissions to the health authorities. The International Council for 
Harmonization (ICH) 6 and FDA’s process validation 7 guidance documents state the importance 
of specifying appropriate process parameter sensitivities, set points, ranges, and adequate process 
controls. Process development studies are crucial to identify the acceptable operating ranges for 
the factors influencing the CQAs of the drug substance and the drug product 28. In this study, the 
F/T process characterization was accomplished with a DoE approach, followed by the construction 
of multi-factor regression models. An initial risk analysis was performed to screen for potential 
DoE variables (Figure 1). According to Table 1, the fill volume, loading distance, freezing 




Protein solutions subjected to F/T process are expected to retain its native state 
conformation and avoid chemical degradation 12. In our study, the retention of LDH activity and 
LDH tetramers varied broadly with the F/T processing conditions, as shown in Figures 6 and 7, 
respectively. A correlation (R2 = 0.75) was also observed between these two CQAs post-F/T 
(Figure 8), which is in agreement with previous reports stating that the fully assembled state of 
multimeric proteins, such as LDH, are more stable and more biologically active than dissociated 
subunits 18.  
Multi-factor models were developed based on the DoE results. These models can be used 
to optimize the F/T process, predict protein CQAs, establish set-points and limits, evaluate the 
design space, and develop a process control strategy 21. All main model factors investigated were 
found to affect % initial LDH activity and % loss of tetramers in a manner that is significant both 
statistically (p<0.05) and in magnitude (>25%, activity; >1.1% loss of tetramers; Table 2). 
Nevertheless, the parameter that most strongly affects the % initial LDH activity was the loading 
distance among the containers. Allowing a minimum separation distance of 5 cm among the 
containers can positively affect the protein activity response in 50.6%. Whereas, the parameter that 
most strongly minimized the % loss of tetramers was the set freezing temperature towards the 
lower range of -80 °C. Similarly, Roessl et al. 29 characterized the F/T behavior of LDH in 
phosphate buffer in a 700 mL controlled rate F/T system and found that the target temperature 
between -10 to -38 °C was the parameter that most strongly affected LDH activity recovery and 
aggregates formation. 
The DoE studies helped to increase process knowledge by revealing relationships, 
including multivariate interactions between the F/T process parameters and the resulting CQAs of 




for uncontrolled F/T of the model protein solution in 1 L bottles. The critical process parameters 
should be controlled to ensure that the drug product is of the desired quality, according to ICH Q8 
guidance 6. 
 
2.6.2.1 Influence of freezing temperature, freezing rate, and the glass transition temperature on 
LDH stability 
Improved protein stability post-freezing correlated with both faster freezing rates and lower 
temperatures. Because of the procedural confounding between these two processing conditions, 
their individual contributions to the protein CQAs could not be resolved in the DoE study. An 
additional evaluation was then performed (Figure 12). Frozen storage for 30 days at -20 °C resulted 
in minimal CQAs changes compared to 24 hours freezing, at a fixed thawing condition. 
Mezhebovsky et al. 39 also observed that long term frozen storage at -80°C of a monoclonal 
antibody in phosphate buffered formulations resulted in no additional aggregation compared to 
one F/T cycle. These findings suggest that protein degradation occurs most likely during the F/T 
event rather than during the long-term storage. 
When solidification is complete, the protein and other solutes are concentrated into a highly 
viscous amorphous matrix with a characteristic temperature called the glass transition temperature 
of the maximally concentrated matrix (Tg’). Above the Tg’, diffusion is still relevant, and the 
molecular relaxation, viscosity, and mobility phenomena are highly sensitive to temperature with 
a Williams–Landel–Ferry (WLF) type of dependence 40. Storage temperature near and above the 
Tg’ allow (partially) unfolded molecules with sufficient mobility to serve as nuclei and to interact 
with their neighbors to form aggregates over time. Molecular mobility also fosters crystallization 




during freezing. Phase separation over time can lead to protein destabilization as the cryoprotective 
effect is lost upon excipient crystallization 36. Below the Tg’, however, viscosity increases 
dramatically, and diffusion is strongly hindered; even if some protein molecules are unfolded in 
the glassy matrix, further unfolding or aggregation would be impaired by the lack of mobility 29. 
Therefore, protein stability is thought to be improved at temperatures below Tg’ during F/T 
processing and storage 27. In agreement with that, our findings revealed that at the same initial 
freezing rate, lowering the final storage temperature to -80 °C improved the retention of LDH 
activity and LDH tetramers after a 30 days frozen storage. 
In general, storage at lower temperatures is preferred due to the decelerated rates of adverse 
reactions below Tg’, but also because, practically, the freezer temperature will not be the same at 
all locations. A ± 5-10 °C variation is common, which lead to a partial unfrozen state of bottle 
contents stored close to the phase transition temperature. Also, storage at higher temperatures, 
closer to the eutectic temperature of salts, can cause additional stresses due to the dissolution and 
recrystallization of salts upon temperature cycling of freezers. However, the lower the storage 
temperature, the higher will be the cost for energy, equipment, and operational logistics 4. 
Roessl et al. 29 unexpectedly found a higher retention of LDH activity in phosphate buffer 
post-F/T at the highest tested freezing temperature of -10 °C (the target temperature was varied 
from -10 to -38 °C), which was claimed to be associated with a smaller pH drop. However, the F/T 
performed at -10 °C was also correlated with a greater formation of aggregates investigated by 
size exclusion chromatography, which is a more reproducible assay compared to the LDH activity 
assay.  
F/T can lead to irreversible damage to protein molecules, which is manifested by a loss of 




stresses arising during freezing. For example, denaturation of proteins at the ice-liquid interface 
has been reported for many proteins 31,32. Another consequence of the ice formation is the freeze-
concentration of all solutes remaining in the unfrozen solution, including proteins. Apart from the 
up-concentration of solutes, which may accelerate bimolecular reactions leading to protein 
aggregation, phase separation may also occur as a consequence of freeze-concentration 33.  
Excipients such as mannitol, sorbitol, and certain buffer salts may crystallize, the former resulting 
in substantial pH shift 34–37.  
Distinct freezing rates culminates in different stresses arising during freezing. For this 
reason, an ideal freezing rate should be defined for each protein molecule and formulation, based 
on its intrinsic susceptibility. For proteins prone to surface denaturation at the ice interface, a 
smaller interfacial area with larger ice crystals (slower freezing rate) would be preferable. Other 
protein molecules, however, are more susceptible to the consequences following freeze-
concentration. In this case, a slower freezing rate would not be recommended because it allows the 
freeze-concentrated matrix to get closer to its maximal concentration, and also lengthen the time 
of protein exposure to the freeze-concentrated and/or pH-altered medium before the formation of 
a glassy matrix, when there is still enough mobility to damage proteins 12. 
In our studies, the most remarkable improvement in protein stability was observed after 
frozen storage initiated by a rapid freezing rate (0.2 °C/min), compared to a 0.05 °C/min freezing 
rate. Improved LDH stability at faster freezing rates suggests that the dominant mechanism for 
LDH inactivation at large-scale F/T is not mediated by the ice surface effects, contrary to previous 
reports for the same protein in small volumes 15,38. Roessl et al. 29 reached the same conclusion; 
instead, they speculated that pH shift of the sodium phosphate buffer system 34,35,41 was the major 




does not show significant pH change upon freezing 42, and buffer-induced pH shift was ruled out 
as a destabilization factor. Besides, we found better LDH CQAs at higher freezing rates, which 
induces the formation of a larger ice surface area and would also induce extensive surface 
denaturation for susceptible molecules. Overall, the mechanism of LDH destabilization in histidine 
buffer upon large-scale freezing was correlated to the slower F/T process and was then 
hypothesized to be governed by the degree of solutes heterogeneous distribution within the frozen 
bulk and the residence time at the freeze-concentrated reactive environments. 
 
2.6.2.2 Influence of thawing time, interaction with ice surfaces and end-point temperature on LDH 
stability 
The thawing process is typically longer compared to the freezing process. To avoid 
overheating during thawing, there is a limited temperature differential driving the heat transfer. 
Another reason relies on the lower thermal conductivity of ice compared to liquid water 4. 
Faster thawing at room temperature and no visible ice as the end-point condition correlated 
well with the best remaining LDH activity and LDH tetramers post-F/T. Our findings agreed with 
general recommendations for thawing, stating that the process should be completed as rapidly as 
possible, without the presence of ice, with minimal foam, and avoiding formation of hot spots 
within the solution. Besides, thawing should be appropriately controlled to ensure that container 
temperatures do not exceed allowable limits for the drug product 4,12. The thawing end-point at no 
visible ice condition resulted in better retention of the protein CQAs due to the shorter residence 
time of the protein in the freeze-concentrated reactive environment and also because of the lower 
temperature developed within the solution (< 7 °C), compared to the end-point at 18 °C.  




the solution, however, it demanded 46 hours for the visual observation of no ice and resulted in 
the lowest LDH quality attributes. Extended thawing times can lead to protein degradation due to 
the prolonged protein exposure to both ice-liquid interfaces and reactive concentrated gradients 4. 
Hence, faster thawing at warmer temperatures should be considered over thawing at refrigerated 
conditions, wherever feasible.  
 
2.7 CONCLUSIONS 
The basic rule stated in the literature for F/T processing of protein solutions is that an 
optimum freezing rate should be defined for each protein, and thawing should generally be as rapid 
as possible 12. Contrary to previous studies performed at small-scale, faster freezing retained both 
higher LDH activity and LDH tetrameric quaternary structure at 1 L bottles. Therefore, both 
freezing and thawing processes should be expedited to minimize the residence time of LDH in the 
freeze-concentrated reactive environment.  
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DoE – Design of experiments 
F/T – freeze-thaw 
LDH – L-Lactate dehydrogenase 
RMSE – root mean square error  
SEC – size exclusion chromatography 
Tc – thermocouple 





















Table 1: F/T process parameters. A response surface model was constructed with the main factors 
described at groups A and B; 28 runs performed at fixed -50°C freezing temperature. Additional 
18 full factorial runs were performed at fixed 5 cm loading distance but varying with the main 
factors described at groups B and C.  
Loading configuration and 
distance among bottles A Fill volume (%) 
B
 Thawing method 
B
 Freezing temperature 
C
 
1 cm, 5 cm, 10 cm (full loading) 




without forced air flow 






























Table 2. Statistically significant model factors and their effect size on the responses 
𝐸𝑓𝑓𝑒𝑐𝑡 𝑠𝑖𝑧𝑒 = 2 × 𝑠𝑐𝑎𝑙𝑒𝑑 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 
























Intercept 82.46 0.65 
Thawing method[forced-air] 16.83 -0.66 
Thawing method[no forced-air] -16.83 0.66 
Freezing temperature -16.68 1.13 
Fill volume -12.60 0.59 
Loading distance 25.32 -0.72 
Thawing method[forced-air] * Fill volume [70%] 7.84 -0.27 
Thawing method[no forced-air] * Fill volume [70%] -7.84 0.27 
Freezing temperature * Fill volume [70%] -10.04 0.61 
Freezing temperature * Thawing method[forced-air] 4.90 -0.62 
Freezing temperature * Thawing method[no forced-air] -4.90 0.62 
Thawing method[no forced-air] * Loading distance [5 cm] 6.36 NS 
Thawing method[forced-air] * Loading distance [5 cm] -6.36 NS 
Fill volume [70%] * Loading distance [5 cm] -5.47 -0.58 
Thawing method[forced-air] * Fill volume [70%] * Loading distance [5 cm] 11.96 NS 
Thawing method[no forced-air] * Fill volume [70%] * Loading distance [5 cm] -11.96 NS 
Thawing method[forced-air] * Fill volume [70%] * Freezing temperature    NS -0.34 




Table 3. Mean and standard deviation (SD) of the main process parameters resulting in highest 



























 % Initial LDH activity % Loss LDH tetramer 
Factors Mean SD % of Total Mean SD % of Total 
Freezing temperature (°C) -65 11 - -70 10 - 
Fill volume (%) 70 12 - 75 10 - 
Loading distance (cm) 8.6 1.0 - 8.4 1.1 - 





























Figure 2. Heterogeneous F/T profiles within a 1 L bottle containing 700 mL of 10 µg/mL LDH in 
20 mM histidine buffer, pH 7.0, frozen at -50 °C and thawed at room temperature with forced air-





















Figure 3. Apparent velocity of the freezing front inside a 1 L bottle upon freezing at either -20 °C, 
-30 °C, -50 °C, and -80 °C (a). Results depicted for the full loading configuration (9 bottles) at 5 
cm, and 70% fill volume. The temperature was recorded at six different locations within the bottle, 
represented by the black dots (b). The arrows represent the direction and magnitude of the freezing 























Figure 4. Freezing rate varying according to the (a) loading distance among nine containers (1 cm 
to 10 cm apart) or a single container (30 cm) at -50 °C; (b) set freezer temperature at 5 cm loading 
distance; and (c) fill volume of the solution inside 1 L polycarbonate bottle at -50 °C. Significant 


























Figure 5. Thawing rate varying with (a) loading distance among containers; (b) thawing method; 
and (c) fill volume. Thawing followed freezing at -50 °C. Significant difference were observed 


























Figure 6. Recovery of LDH activity post one F/T cycle at varying freezing set temperature, thawing 
methods, and solution fill volumes. Results are reported for full loading configuration, with nine 
containers at 5 cm apart. Columns and error bars represent the average and SD of three replicates 




















Figure 7. Formation of LDH non-native species (% loss of tetramers) post one F/T cycle at 
varying freezing set temperatures, thawing methods, and solution fill volume. Results reported 





















Figure 8. Correlation between the LDH activity and % loss of tetramers after one F/T cycle of 10 
µg/mL LDH in 20 mM histidine buffer, pH 7, in 1 L polycarbonate containers. Linear regression 





















Figure 9. Combined model profiler for (a) % initial LDH activity and (b) % loss of LDH tetramers 





















Figure 10. Model profiler showing the influence and interaction of the main F/T processing factors 
















Figure 11. Model profiler showing the influence and interaction of the main F/T processing factors 















Figure 12. Effect of both 0.05 °C/min and 0.2 °C/min freezing rates on LDH degradation. A single 
1 L bottle containing 700 mL of the LDH solution in buffer was frozen for 24 hours at -20 °C 
(dashed column) or 30 days (solid columns) at either -20 °C or -80 °C and thawed at room 





















Figure 13. Impact of several thawing conditions on the % initial activity and % loss of tetramers 
post one F/T cycle, following a fixed freezing condition at -80 °C. A single 1 L bottle containing 
700 mL of the protein solution was thawed at room temperature (RT) with (dashed column) or 
without (solid columns) forced air-flow, or at a cold room. The end-point for thawing was either 
at 18 °C reading at the geometrical centered thermocouple inside the solution or the visual 



















Large-Scale Freeze-Thaw Process of Protein Solutions: Study of the Relative Contributions 























The present study investigated the influence of different freezing and thawing (F/T) rates 
on protein stability at large-scale manufacturing setting. F/T at faster rates better maintained the 
LDH enzymatic activity and native tetramers. These protein quality attributes resulted from the 
relative magnitude of stresses arising during freezing, which are capable of denaturing proteins. 
Therefore, to better understand the underlying mechanisms of protein denaturation in the bulk 
freezing process, we characterized the relative contributions of freezing-induced stresses, such as 
the ice surface area, extent of solutes freeze-concentration, and residence time in the low-viscosity 
fluid state to the protein instability post-F/T cycles at distinct rates. The present study represents 
the first time that ice surface area was measured in dried samples from large-volume protein 
solutions. The results demonstrated that the surface area of the ice formed strongly depended on 
the freezing rate and the position of the sample inside the 1 L containers (center versus edge 
samples). The ice-cored samples from the solution frozen at the faster freezing rate of 0.215 °C/min 
exhibited close to 5-fold higher ice surface area compared to the samples frozen at 0.031 °C/min. 
However, the examined ice surface area did not explain the protein stability maintained at higher 
freezing rates. On the other hand, the freeze-concentration profiles correlated well with the 
outstanding LDH stability at faster freezing rates. Our results implicate freeze-concentration of 
solutes as the primary cause of LDH degradation in large-scale F/T processing. Overall, the LDH 
quality attributes were better maintained at a faster freezing rate, which led to a more homogeneous 
protein distribution throughout the geometry of the bottle. Besides, the faster freezing rate 






3.2 KEYWORDS: freeze-thaw, freeze-concentration, ice surface area, protein stability 
 
3.3 INTRODUCTION 
Freezing is one of the preferred routes of stabilizing biotherapeutic solutions. Bulk protein 
solutions are routinely frozen for storage and shipment and then thawed before drug product fill 
and finish unit operations 1. However, sub-optimal freezing and thawing (F/T) processes may also 
pose risks to proteins. F/T may induce structural perturbations leading to loss of therapeutic 
activity and formation of immunogenic aggregates 2. The present study is part of the current 
emphasis on rational design of F/T processes to overcome protein stability issues 3,4. 
Protein structural perturbation and degradation during freezing result from the stresses of 
cold denaturation and ice formation. The cold-labile protein molecules undergo cold denaturation 
on exposure to subzero temperatures 5. Other protein molecules are rather denatured by the 
deleterious stresses following ice formation and growth. Dramatic changes occur when ice forms, 
not only because of the presence of the ice-aqueous interface itself but also because of the freeze-
concentration of solutes and the cascade of other stresses that follow from the increased 
concentration of solutes in the remaining liquid phase. The effects of ice formation are strongly 
dependent on the degree of undercooling and freezing rate. Generally, high undercooling means 
high nucleation rates and a high specific surface area (SSA) for the ice formed 6. 
Experimental evidence suggests partial unfolding of proteins at the ice: freeze-concentrate 
interface 7. Another consequence of ice formation is the progressive freeze-concentration of 
solutes, as pure water crystallizes and is removed from the remaining solution. Typically, solutes 
(e.g., buffer salts, stabilizers), as well as the protein itself, become 10-15 times more concentrated 




ionic strength of the solution, which can perturb and destabilize proteins 9. Also, the up-
concentration in protein may trigger bimolecular interactions leading to the formation of 
aggregates. Freeze-concentration can also result in differential precipitation of buffer salts and 
dramatic changes in pH, which can destabilize proteins 10. Large pH shifts have been demonstrated 
in sodium and potassium phosphate buffers upon freezing 11. For example, the pH in a solution 
containing sodium phosphate originally formulated at pH 7.0 may drop below pH 4.0 in the freeze 
concentrated solution. Another potential consequence of freeze-concentration is phase separation 
due to excipients crystallization 12 or between the protein and polymeric excipients in the 
amorphous phase 13. 
The deleterious effects of freezing and F/T processing are found in numerous studies 1,14–
21. However, the individual contributions of cold denaturation, solutes freeze-concentration, and 
ice surface area are highly convoluted in these studies. Bhatnagar et al. 3,6 uncovered the individual 
contributions of the freezing induced-stresses to protein stability by applying small-scale 
experimental protocols (5 mL filled into glass vials). Although, the relative F/T-stress contribution 
to protein destabilization at practical manufacturing-scales (1 L or larger containers) is mostly 
unknown. Therefore, the current study at large-scale investigates the effect of both ice-aqueous 
interfacial area and freeze-concentration of solutes to the resulting bulk-averaged stability of a 
model protein, lactate dehydrogenase (LDH). The contribution of cold denaturation was not 
evaluated since there is evidence suggesting that cold unfolding may not significantly contribute 
to irreversible denaturation of proteins during freezing, including LDH 6. 
The combined effects of the F/T-induced stresses are usually determined by monitoring the 
protein conformational changes and biological activity. Though, the extent of protein damage 




Besides, processing parameters leading to different F/T rates are key factors. Therefore, F/T 
process understanding and efficient process development are crucial to minimize F/T adverse 
effects 8. In a previous study, we presented data from F/T design of experiments (DoE) studies 
revealing the critical process parameters and the design space for optimal uncontrolled F/T cycles 
with LDH solution in 1 L polycarbonate containers. Among the 46 F/T runs performed in the DoE 
study, the conditions leading to the best and worst protein stability were selected for the further 
mechanistic investigation of freezing-induced stresses discussed in the present study. Here, we 
investigated the relative contribution of solutes freeze-concentration and ice surface area to the 
bulk-averaged protein stability. The magnitude of such destabilizing stresses greatly depended on 
F/T processing rates, and so did the LDH protein stability.  
 
3.4 MATERIALS AND METHODS 
3.4.1 Materials 
L-Lactate dehydrogenase (LDH) from rabbit muscle in ammonium sulfate suspension was 
purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). L-histidine monohydrochloride 
monohydrate and L-histidine were obtained from VWR International (Philadelphia, PA, USA). 
 
3.4.2 Solution preparation  
LDH was dialyzed against 20 mM histidine buffer, pH 7.0, with a 3.5 K MWCO membrane 
at 4 °C overnight before use. The concentration of LDH was determined from UV absorbance 
(extinction coefficient 1.44 mL/mg.cm at 280 nm) 22. The protein solution after dialysis was 





3.4.3 Freeze-thaw cycles 
As reported in the previous chapter (Chapter 2), the protein solution was filled into 1 L 
square polycarbonate containers at 50%, 70% or 90% v/v fill volume. Solutions were frozen using 
upright stagnant-air freezers at distinct set temperatures (-20 °C, -30 °C, -50 °C, and -80 °C). F/T 
was performed at single or full loading configuration, i.e., nine bottles arranged in a 3x3 array. The 
distance among multiple containers was fixed at 1 cm, 5 cm, and 10 cm apart. After 24 hours of 
freezing, the bottles were thawed at room temperature in the presence or absence of a forced air-
flow at 98 fpm. Immediately after thawing, LDH critical quality attributes were investigated in a 
sample withdrawn from the homogenized bulk.   
The temperature changes during F/T was monitored by six type T thermocouples placed at 
three different heights at the radial center and edge locations inside each solution (as described in 
Chapter 2). All temperature profiles were recorded with a Data Logger (MicroDaq, SD-947-KIT, 
Contoocook, NH, USA). The freezing time was defined as the period elapsed from the beginning 
of the freezing process to when the temperature decreased to -20 °C. The thawing time was defined 
as the period from the lowest temperature until the temperature rose to 18 °C at the geometrical 
centered thermocouple. F/T rates were calculated by dividing the gradient in temperature by the 
required time to complete F/T, and reported as °C/min.  
 
3.4.4 Assessment of LDH critical quality attributes  
Post each F/T cycle, a representative sample from the homogenized bulk was filtered (0.22 
µm filter) and analyzed for the retention of LDH enzymatic activity and the retention of LDH 
tetrameric structures.  




NADH, which is detected by a colorimetric (450 nm) assay (LDH activity kit, Sigma-Aldrich Co., 
USA). For each sample, the enzymatic activity of three replicates were determined and averaged. 
The obtained LDH activity was normalized by the LDH concentration in each sample and 
expressed as the remaining percentage (%) of activity relative to the unfrozen solution.  
Size exclusion chromatography (SEC) was used to determine the extent of LDH tetramer 
recovery post-F/T. Analyses were performed on an 1100 Agilent HPLC system coupled with 
Chemstation software®. Samples were separated on an SEC column (TSKgel™G3000SWXL, 7.8 
mm 30 cm, 5 µm; Tosoh Bioscience, San Francisco, CA) maintained at 25 °C. The mobile phase 
was 100 mM phosphate buffer with 0.2 M NaCl (pH 7.0) delivered at 1.0 mL/min. Elution was 
recorded on a diode array UV detector (220 nm). Results are reported as the loss percent (%) of 
LDH tetramer contents relative to the initial values before F/T.  
Multivariate linear regression models were constructed for the critical quality attributes of 
LDH (JMP® 14.0, SAS Institute). The responses were modeled against the main effects of freezing 
rate and thawing rate, their two-way interactions and quadratic terms. A significance level of 95% 
was applied throughout the analysis.  
The primary objective of the current study was to determine the direct impact of F/T rates 
on protein stability and to mechanistically understand the relative contribution of the stresses 
arising during freezing to the LDH bulk stability post F/T cycles. This study builds upon our 
previous report (Chapter 2) in which 46 bulk F/T runs revealed the effect of several experimental 
conditions on F/T rates and on the protein critical quality attributes. From this previous study, we 
selected the F/T conditions which resulted in the best- and worst-protein stability. Thus, additional 
1 L bottles containing the LDH solution in histidine buffer were frozen at the -20 °C freezer (900 




respectively. After 24 hours upon confirmation of bulk solutions being completely frozen, the 
bottle content was sampled and analyzed as described below for solutes freeze-concentration and 
ice surface area measurements. 
 
3.4.5 Determination of macroscopic solutes freeze-concentration 
Each frozen solution was axially cut into five or eight even layers using a compound miter 
saw with a pre-cooled blade (Ryobi TS1345L). Each one of these layers (1.5 cm each; Figure 1a) 
was subsequently divided into five even columns and, finally, each column was sliced into five 
even rows, resulting in 125 ice-cored cubes (approximately 4 mL each) per 50% filled bottle and 
200 ice-cored cubes per 90% filled bottle. Afterwards, 7 representative samples per layer were 
selected resulting in 35 samples per 50% filled container (Figure 1b), and 56 samples per 90% 
filled container (Figure 1c).  
The selected samples were individually thawed at room temperature and filtered through a 
0.22 µm filter before analyses. Ice-cored samples were analyzed for the percentage of loss in LDH 
tetramers and LDH enzymatic activity according to the methodology described in the previous 
section. Nevertheless, the protein concentration was determined from the absorbance at 595 nm 
applying a Bradford assay 23 (Coomassie Plus Bradford Assay Kit 23236, Thermo Scientific, 
Rockford, lL USA). 
 
3.4.5.1 Homogeneity score 
A homogeneity score (H-Score) was created and defined according to equation 1 to 
quantify the homogeneity of solute distribution post-freezing. HS was calculated for LDH 




𝐻𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦 𝑆𝑐𝑜𝑟𝑒 = 1 − (
𝑀𝐴𝐷 (𝑋)
𝑀𝑒𝑑𝑖𝑎𝑛 (𝑋)
)                         Equation 1 
where X is the protein concentration measurement and MAD is the median absolute deviation 
around the median of the measurements as defined by equation 2. 
𝑀𝐴𝐷 = 𝑚𝑒𝑑𝑖𝑎𝑛 (|𝑋𝑖 − 𝑚𝑒𝑑𝑖𝑎𝑛 (𝑋)|) ; i = 1, …, 35 or 56              Equation 2 
In the case of a perfectly homogenized system H-Score = 1; introduction of heterogeneity 
gradually decreases the H-Score. 
 
3.4.6 Determination of ice surface area 
The role of the ice: aqueous interfacial area on LDH degradation was investigated by the 
determination of the ice surface area (SA) from Brunauer-Emmett-Teller (BET) surface area 
analysis of freeze-dried samples. 
The frozen bottles were sliced into representative samples from the center, edge or corner 
of the container. The ice-cored samples from distinct regions within the bulk were dried in a 
LyoStar™ 3 (SP Scientific, Stone Ridge, NY). Briefly, the frozen samples were loaded onto pre-
cooled shelves at -40 °C. The same shelf temperature was held for 20 minutes. For primary drying 
the shelf was heated at 0.5 °C/min to -33 °C and the chamber pressure was set at 100 mTorr. When 
the Pirani gauge reading converged with the capacitance manometer reading, the shelf temperature 
was raised to 40 °C at 0.1 °C/min and held for 5 h at the same chamber pressure setting. 
Specific SA analysis (measured SA divided by the weight of the freeze-dried powder, 
reported as m2/g) was carried out by the method of gas adsorption isotherm. The BET analyzer 
used was Flowsorb II 2300 (Micromeritics Instrument Corporation, Norcross, GA). The 
instrument calibration was performed with 100% Krypton gas and a mixture of 0.1 mol% Krypton 




moisture adsorption and degassed for 2 hours at 40˚C under the flow of the helium and krypton 
mixture prior to the SA measurement. After degassing, the sample tube was immersed into liquid 
nitrogen to carry out a single point analysis of Krypton adsorption onto the samples. Desorption 
was followed by dipping the sample tube in a water bath at room temperature. The ice surface area 
(reported as m2/100 mL of solution) was calculated from the average SSA values of four 
independent measurements along with the standard deviations using Equation 3.  
 
𝐼𝑐𝑒 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 (
𝑚2
100 𝑚𝐿
) = 𝑆𝑆𝐴 (
𝑚2
𝑔
) 𝑥 % 𝑠𝑜𝑙𝑢𝑡𝑒 (
𝑔
100 𝑚𝐿
)              Equation 3 
 
3.5 RESULTS 
3.5.1 Effect of freeze-thaw rates on LDH critical quality attributes  
Common practice in the biopharmaceutical industry is to assess the relative stability of the 
compound of interest through its exposure to a range of stress factors. The present study evaluated 
the effect of freeze-thaw stress, one of the most common stress factors encountered during 
manufacturing and processing 24. The F/T cycles employed several study conditions, which 
resulted in different F/T rates. Figure 2 shows the overall effect of F/T rates on LDH denaturation. 
Freezing occurred for 24 hours. Thawing time was not fixed, instead, the end-point depended on 
18 °C being detected inside the solution. 
Following the freeze-thaw cycles, the end-point homogenized material was sampled and 
tested via multiple assays to evaluate the potential impact of the F/T rates on the protein quality. 
The F/T rates varied significantly, from 0.02 °C/min to 0.22 °C/min for the freezing rate and from 
0.03 °C/min to 0.14 °C/min for thawing rate.   




Nevertheless, data from 46 F/T runs suggested a cut-off preventing further CQAs improvement. 
Increasing the freezing rate from 0.02 °C/min to 0.15 °C/min had the steepest effect to retain LDH 
activity and to avoid the loss of tetramers; further increase of the freezing rate appeared to have no 
further impact on the responses. Similarly, increasing the thawing rate up to 0.10 °C/min resulted 
in steep increase in LDH activity and a decrease in the loss of tetramers, with no further impact 
after that. 
The significant effect of the F/T rates on the protein quality outputs were estimated from 
multivariate linear regression models. The resulting model for the % initial LDH activity (Figure 
3a) is statistically significant (p<0.0001) with R2 equal to 0.81 and RMSE of 5.54. The constructed 
model for the % loss of tetramer (Figure 3b) is also statistically significant (p<0.0001) with R2 
equal to 0.84 and RMSE of 0.26.  
Table 1 shows the statistical significance of the model factors and their corresponding 
magnitude in influencing both responses. The two main model factors investigated were found to 
affect the % initial LDH activity and the % loss of tetramers in a manner that is significant both 
statistically (p<0.05) and in magnitude. Thawing rate had the highest effect size (39.24%) favoring 
maximum LDH activity post F/T, followed by the freezing rate (20.12%). The quadratic of the 
thawing rate, however, negatively influenced the LDH activity response in about 14%. The 
variability in the % loss of tetramer response was most strongly influenced by the freezing rate, 
followed by the thawing rate. The quadratic terms of both freezing and thawing rates and their 
two-way interaction were also statistically significant to the loss of LDH tetramers. 
Visualization of the interaction between the main factors can advance process 
understanding. Thus, a surface profiler was constructed to evaluate the impact of the F/T rates on 




minimal loss of LDH quaternary structures were predicted for F/T runs performed at faster rates. 
The measured bulk-averaged protein quality attributes resulted from the relative magnitude 
of the stresses arising during freezing, which are capable of denaturing proteins. The degree of 
protein damage was closely related to the rate of freezing and thawing. Therefore, we hypothesize 
that F/T processes performed at different rates fosters the development of distinct stresses 
perturbing the protein stability. To better understand the mechanisms of protein denaturation in 
the bulk freezing process, the conditions which led to the slowest (about 0.031 °C/min) and fastest 
(about 0.215 °C/min) freezing rates (based on the results from 46 F/T cycles) were selected and 
examined for the ice surface area and the degree of solutes freeze-concentration. 
 
3.5.2 Assessment of ice surface area 
Specific surface area analysis was carried out to determine the role of the ice-aqueous 
interface on LDH quality attributes. Each frozen protein solution was dissected into representative 
samples from the center, edge or corner regions within the 1 L bottles. The ice surface area was 
obtained from BET surface area analysis of the freeze-dried samples (Figure 5). 
The ice surface area values were reported as m2/100 mL of solution (Equation 3) instead 
of the conventionally employed units of m2/g of the freeze-dried solid to include the effect of 
solutes freeze-concentration. The solids content varied in the ice-cored samples from distinct 
locations within the bulk.  
The protein solution filled into the 1 L bottle at 50% fill volume and frozen at -80 °C 
resulted in the higher freezing rate of about 0.215 °C/min, compared to the 0.031 °C/min freezing 
rate applying 90% fill volume and -20 °C freezer. As expected, higher freezing rate resulted in 




containers. An increase in the ice surface area from 0.77±0.01 to 3.5±0.28 m2/100mL of solutions 
was observed when the center samples were exposed to the faster freezing process. Moreover, the 
distance of the sample from the active cooled surface of the container had an impact on the ice 
surface area developed. Edge samples, closer to the container wall, exhibited smaller ice surface 
area compared to ice-cored samples from the center of the bottles. 
 
3.5.3 Extent of solutes freeze-concentration 
Ice formation during freezing leads to progressive freeze-concentration of solutes 25. 
Extensive freeze-concentration exposes protein molecules to heterogeneous microenvironments 
throughout the bottle. Such high polarized protein concentration and heterogeneity in solutes 
distribution may lead to protein molecules instability in their microenvironment 26. Thus in this 
study, frozen solutions of 500 mL and 900 mL in a 1 L square bottles were evenly cut into 125 and 
200 cubes, respectively, in order to obtain a detailed 3D profile of the protein distribution. LDH 
concentration was obtained and profiled from the ice-cored samples (Figure 6).  
The solute distribution profiles in the frozen matrix were highly dependent on the freezing 
rate. Overall, solutes distributed more evenly post fast freezing compared to slow freezing 
conditions. For instance, for the 50% filled solution into the 1 L bottle and frozen at -80°C  the 
protein concentration varied from 70% to 200%, and majority of the ice-cored samples from 
distinct bulk regions showed unaltered LDH concentration post-freezing. Whereas, after slow 
freezing rate, applying 90% solution fill and -20°C freezer conditions, the protein concentration 
varied extensively, from 44% to 450%. 
In addition, the protein concentrated towards the center and bottom of the bottles after 




most concentrated samples were found at the radial center and towards the bottom axial layers. 
The same method was used to study the distribution in LDH enzymatic activity across the 
container. 3D profiles of LDH activity changes post freezing were generated for the protein 
solution frozen at distinct freezing rates (Figure 7). 
More uniform protein distribution throughout the geometry of the bottle after fast freezing 
also correlated with enhanced protein stability. The material at the center of the container showed 
higher LDH activity compared to the samples from the edge and top layer. Moreover, Figure 8 
shows the average change in LDH activity and loss of tetramers from the ice-cored samples for 
each frozen bottle. 
For the solutions frozen at the higher freezing rate, the average LDH activity was closer to 
the initial activity (33.2%), and there was only a slight increase in the average loss of LDH 
tetramers of 0.63%. On the contrary, for the solution frozen at the slower freezing rate, the loss of 
LDH tetramers was significantly higher at 2.24%, and the averaged LDH activity was only 13.8% 
of the initial unfrozen solution.  
In order to further quantify the heterogeneous solute distribution in the frozen mass, we 
devised a homogeneity score (Equations 1 and 2) and calculated the scores for LDH concentration 
post two different F/T study conditions. Table 2 shows the homogeneity scores calculated from 
either 35 or 56 ice-cored samples in each bottle filled with 500 mL or 900 mL of protein solution, 
respectively.  
According to Eq. 1, the smaller the median absolute deviation is in the data set, the more 
homogeneous the protein distribution is. In the case of a perfectly homogeneous solution, every 
sample is the same. Hence the median absolute deviation is 0 and the H-Score is 1.  Faster freezing 




that higher freezing rates resulted in more homogeneous distribution of the protein concentration 
within the frozen solutions. 
Overall, better bulk averaged protein stability parameters correlated with higher ice surface 
area and higher homogeneity score for the protein concentration; such conditions were achieved 
at a higher freezing rate. 
 
3.6 DISCUSSION 
3.6.1 LDH stability as a function of freeze-thaw rates 
Destabilization of proteins during freezing can be induced by the formation of ice: freeze-
concentrate interfaces, cold denaturation and solutes freeze-concentration 7,27. The LDH cold 
denaturation temperature was reported to be -28 °C in the absence of stabilizers in an unfrozen 
solution 28. Cold denaturation of LDH is thus possible within the temperature range applied in the 
current study (from -20 °C to -80 °C). Although, the effects of cold denaturation on LDH stability 
were not considered due to previous reports on its negligible contribution to the overall freeze 
denaturation of LDH 3,6.  
Another predominant factor in drug substance stabilization during freeze-thaw is the 
residence time in the low-viscosity fluid state 29. Different freezing parameters, particularly the 
freezing rate, can impact the concentration and temperature history and therefore the residence 
time in a concentrated but relatively fluid system and thus, might also highly impact protein 
stability 29. Different thawing rates also impact the protein residence time in highly reactive 
environments, because the concentration gradients developed during freezing will persist during a 
static thawing process.  




maintenance of LDH native tetrameric structures and improved the recovery of LDH activity post-
F/T processing (Figures 2 and 4). Increasing the freezing rate from 0.02 °C/min to 0.2 °C/min 
increased the LDH activity from about 50% to 95% and reduced the loss of tetramers from about 
1.7% to negligible values close to zero. Similarly, increasing the thawing rate from 0.04 °C/min 
to 0.14 °C/min increased the LDH activity from about 60% to 95% and reduced the loss of 
tetramers from about 1.5% to negligible values close to zero.  
The LDH solutions were formulated with histidine buffer, which does not induce 
significant pH shift upon freezing 30. Thus, not only cold denaturation but also the effects of pH 
shifts were ruled out as the primary causes for LDH instability as a function of F/T rates. 
Consequently, the extent of both ice surface area and freeze-concentration most strongly 
determined the degree of LDH degradation post F/T processing. The relative contribution of these 
two freezing-induced stresses to the overall LDH stability was then further examined. 
 
3.6.2 Consequences of ice formation to the overall freeze degradation of LDH 
Protein destabilization at interfaces is speculated to depend on strong electric fields 
generated by preferential incorporation of certain ionic species into the forming ice crystals 31,32. 
The strength of the electric field will vary according to the composition of the electrolyte solution, 
concentration of the ionic species, and the freezing rate 29. 
The surface area and morphology of ice crystals are governed by the ice nucleation 
temperature, solution composition, and the freezing rate 3,33,34. Fast freezing usually results in high 
degree of supercooling and therefore, a large number of smaller ice crystals, with a large ice-
aqueous interfacial area 35. Literature suggests that large ice-aqueous interfacial imparts a greater 




The ice specific surface area (SSA) reflects the pore size of a freeze-dried material and, 
assuming no collapse during drying, is a template of the ice crystals formed during freezing. Thus, 
SSA measurements can indicate the size and morphology of the formed ice crystals 34,37. However, 
majority of the published studies have investigated the role of ice surface via indirect 
measurements, through correlations between stability and the process cooling rate 36. Only a few 
studies directly measured the specific surface area of freeze-dried cakes, and these studies were 
conducted in small glass vials 3,29,38,39. 
The most direct evidence for ice surface mediated destabilization of a protein was reported 
by Bhatnagar et al 3, correlating protein unfolding and large ice: aqueous interfacial area developed 
on freezing. The same authors reported that addition of 0.005% w/v Tween 80 resulted in 100% 
retention of LDH activity in either the absence or presence of 2% w/v sucrose, presumably because 
the surfactant avoids enzyme adsorption and denaturation at the interfaces. 
However, to our knowledge, the current study presents the first time that ice surface area 
was measured in dried samples from large-volume protein solutions. The results shown in Figure 
5 demonstrated that the SA of the ice formed during freezing strongly depended on the freezing 
rate and the position of the sample inside the 1 L containers (center versus edge samples). The ice-
cored samples from the solution frozen at the higher freezing rate of 0.215 °C/min exhibited in 
average 4.7-fold higher ice SA compared to the samples frozen at 0.031 °C/min. 
Theoretically, the ice-nucleation temperature defines the number of ice nuclei and thus, 
governs the final ice surface area. In the present large-scale study, freezing of the protein solution 
did not result in any degree of supercooling. In general agreement with previous reports, 
supercooling is rarely seen in large-scale systems but is frequently observed in small-scale freezing 




ice-nucleation temperature. It is speculated that a slow freezing rate can be compared to a short 
annealing phase, during which larger crystals grow at the expense of smaller ones 40, leading to 
the reduced ice surface area observed post slow freezing rate (Figure 5). 
Rodrigues et al 41 observed that the linear ice front velocity increased as the ice front 
propagated toward the center of a cylindrical vessel, as the surface area to volume ratio of the 
unfrozen cylindrical core increased. These findings might explain the lower ice surface area 
measured at edge versus center samples in the present study. Assuming that the entire volume is 
frozen at a constant heat flux at the outer container wall and the sensible heat during freezing is 
relatively small in comparison with the latent heat, the acceleration of the freezing front is simply 
due to the reduction in the mass or volume frozen at a particular radius.  
The LDH quality attributes were better maintained at faster freezing rates, which also 
induced the formation of large ice surface area resulting in large ice-aqueous interfaces. Similar 
findings were reported by Kasper et al 29, in which plasmid/LPEI polyplex particles aggregation 
was avoided at lower ice-nucleation temperatures and faster freezing. Clearly, protein interaction 
with the ice surface is not the only significant destabilization factor for proteins during large-scale 
freezing. Thus, another consequence of ice formation, the freeze-concentration of solutes, was also 
examined to its relative contribution to LDH degradation post F/T. 
In large-scale systems, ice growth is faster at the containers walls than at the center of the 
solution, because of the significant heat transfer distances involved. The ice front will 
progressively travel towards the geometrical center while the solutes are pushed towards later-
freezing regions by diffusion and convection 42,43. Freeze-concentration leads to solute-rich liquid 
phase and might facilitate protein denaturation and aggregation because of an increase in ionic 




The extent of the protein distribution within the frozen matrix was highly dependent on the 
freezing rate. Observations from the 3D scatterplots (Figure 6) and from the homogeneity scores 
(Table 2) revealed a more evenly distribution of the LDH concentration post fast freezing (0.215 
°C/min) compared to the slow freezing conditions (0.031 °C/min). More homogeneous protein 
distribution throughout the geometry of the bottle after fast freezing also correlated with enhanced 
protein stability (Figures 7 and 8).  
Ice-cored samples from the center of the containers exhibited both higher LDH 
concentration and activity. The freeze-concentrate contains high concentrations of LDH, which is 
known to be self-protective at higher concentrations similar to other multimeric enzymes, thereby, 
resulting in higher retention of the enzymatic activity 19,21. For periphery ice-cored samples, 
however, the minimum stability is a result of two adding effects: protein denaturation at ice: liquid 
interfaces and the lower LDH concentration in the freeze-concentrate. 
 
3.6.3 Residence time at freeze-concentrate most strongly influenced LDH stability 
Overall, improved bulk averaged LDH quality attributes parameters correlated with higher 
ice surface area and higher homogeneity score for the distribution of the protein concentration, 
both achieved at a higher freezing rate. 
Since both pH change in the frozen histidine solution and LDH cold denaturation are not 
significant, the only remaining destabilizing stress to the LDH is ice formation. Both ice surface 
area and solutes freeze-concentration are stresses arising from the ice formation. However, the 
examined ice surface area did not explain the enhanced protein stability at higher freezing rates, 
which correlated better with the findings from the freeze-concentration profiles determined from 




correlated with enhanced LDH quality attributes. Our results comparing the stability data for LDH 
in histidine buffer solutions frozen at distinct rates with the stresses following ice formation 
implicate freeze-concentration as the primary cause of degradation.  
In contrast to the present findings, Bhatnagar et al 3 observed that freeze-concentration did 
not result in LDH degradation, instead, the ice surface was responsible for protein irreversible 
denaturation in their small-scale study. However, studies performed in small-scale (2–4 mL) do 
not address the complications created by the relatively large heat and mass transfer dimensions of 
large-scale systems 44. The freezing rates are generally much slower at large-scale, implicating in 
extended residence time of protein molecules in the still fluid reactive microenvironments before 
complete material solidification upon freezing. Besides, the extent of solutes redistribution can be 
directly correlated to the solution volume 45. As a result, solutes redistribution becomes an 
important factor governing product quality at large-scale 46. 
  Also, it was observed that slow freezing to a product temperature of -20 °C was more 
stressful than fast freezing to -80 °C. This observation indicates that most of protein degradation 
occurs early on during ice formation and that further freezing to lower temperatures at a 
sufficiently fast rate does not cause significant additional damage. The time dependence for protein 
destabilization during freezing indicates a kinetic influence. Similar time-dependent process for 
the dissociation of the LDH tetramers into less active dimers and monomers has been reported for 
aging studies following the freeze-thaw process 47.  
The loss of LDH tetramers is likely diffusion controlled, in which molecular mobility and 
time are prerequisites for colloidal interactions leading into multimeric proteins dissociation and 
aggregates formation. Diffusion-controlled reactions follows Stokes-Einstein equation, in which 




constants can be achieved by viscosity driven decrease in mobility and lower temperatures, 
according to Arrhenius kinetics 6. On the other hand, ice formation leads to progressive freeze-
concentration of the solutes in the remaining liquid phase. The freeze-concentration effect with 
concomitant increase in local viscosity was extensively discussed in our previous theoretical 
modeling of freeze-concentration of protein solutions 25. Initially, the rate of bimolecular reactions 
will tend to increase with the molecular crowding caused by freeze-concentration but will 
ultimately compete and later decrease due to the Arrhenius temperature-dependent kinetics.  
The residence time was defined as the period between ice nucleation (around 0 °C for all 
bulk solutions evaluated) and the point at which the bottle contents reached -30 °C. The latter 
temperature is around the Tg’ of the glassy histidine matrix 48, below which particle mobility 
should be limited. Faster freezing mitigated the residence time of protein exposure to both freeze-
concentrated environments and ice-aqueous interfaces. Lower residence times then correlated with 
improved protein stability post F/T cycles. Thus, the time of exposure to freezing-induced stresses 
is of high importance. Moreover, these findings offer experimental evidence that protein stability 
is not only time-dependent during long-term frozen storage but is also highly time-dependent 
already during the freezing process.  
Besides reducing the residence time, other complementary approaches can be used to 
mitigate protein denaturation during F/T. Bhatnagar et al 3 calculated the composition of the 
freeze-concentrate from the liquidus curve at -18 °C and found that the concentration of LDH 
declines from 686 mg/mL at 0.5% w/v sucrose to 75 mg/mL at 3.25% w/v sucrose. Therefore, 
there is a decrease in the extent of freeze concentration of LDH as a function of sucrose 
concentration. Moreover, Roessl et al 18 reported a remarkable increase in LDH activity and 




in Tris-HCl buffer frozen at -30 °C. These findings highlight the importance of the incorporation 
of excipients in the formulation such as stabilizers and surfactants to further minimize protein-ice 
interactions, mitigate the extent of freeze-concentration of solutes, and to prevent overall 
freeze/thaw-induced denaturation and aggregation of proteins. 
 
3.7 CONCLUSIONS 
The residence time of protein molecules in the low-to-moderate viscous state after ice 
formation was implicated as the predominant factor in protein destabilization during freezing. 
During this period, the protein is exposed to freezing-induced stresses, among which the extensive 
freeze-concentration of solutes was identified as the primary cause for protein degradation in bulk-
scale freeze-thaw process. Nevertheless, the residence time was influenced by the applied freezing 
rate, which was thoroughly characterized. The identification of the critical process parameters led 
to optimized freezing rates and mitigated both the residence time and protein degradation. Overall, 
this study provides a better understanding of the underlying stabilization mechanisms involved 
during large-scale freezing, which can be leveraged to design less stressful freeze-thaw processes 
and drug products with improved quality. 
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BET – Brunauer-Emmett-Teller  
CQA – critical quality attribute 
DoE – design of experiments 
F/T – freeze-thawing 
HS – homogeneity score 
LDH – L-lactate dehydrogenase 
MAD – median absolute deviation 
NAD – nicotinamide adenine dinucleotide 
NADH – reduced nicotinamide adenine dinucleotide 
R2 – coefficient of determination 
RMSE – root mean square error  
SA – surface area  
SEC – size exclusion chromatography 
SSA – specific surface area 
















































Table 2. The relative contribution of freezing-induced stresses to the LDH stability post-F/T at 


































Figure 1. Frozen solutions were (a) evenly dissected into vertical layers (1.5 cm each); as 
highlighted in blue, 7 samples were selected from each layer for further analysis, resulting in (b) 
35 samples per 50% filled container and (c) 56 samples per 1 L containers filled with 900 mL of 

















Figure 2. Effect of (a) freezing and (b) thawing rates on protein activity recovery and loss of 
tetramers post one F/T cycle of 10 µg/mL LDH in 20 mM histidine buffer using 1 L bottles. The 















Figure 3. Multivariate regression models comparing the actual and predicted results for (a) 

















Figure 4. Model surface profiler showing the influence of the main model factors to both responses. 
The % loss of tetramers is color-coded according to the blue scale, and the LDH activity is color-
coded according to the red scale. The left-hand area of the profiler shows the effect of the slowest 
tested freezing and thawing rates on the responses. Whereas, the right-hand area of the profiler 

















Figure 5. Ice surface area of freeze-dried LDH solution in 20 mM histidine buffer determined using 
BET surface area analyzer. The ice surface area was obtained by multiplying the measured specific 
SA by the solutes content of each sample. The specific SA was calculated from the average of four 



















Figure 6. Distribution profile of the protein concentration post freezing at (a) 0.215°C/min rate or 
(b) 0.031°C/min freezing rate. Light grey bubbles indicate no change in LDH concentration post-
freezing. Darker blue bubbles indicate bulk regions with lower LDH concentration, whereas darker 




















Figure 7. 3D profile of LDH activity changes in the frozen bulk post (a) 0.215°C/min freezing rate 





















Figure 8. Welch`s t-test analysis of (a) % initial LDH activity and (b) % loss of LDH tetramers by 
















































Storage of protein therapeutics in a frozen state provides operational flexibility for fill and finish 
of drug products and extends the shelf life of protein solutions. However, the freezing process of 
bulk protein solutions leads to progressive freeze-concentration of solutes which may result in 
protein instability. A novel method was designed to study the factor(s) that may impact solutes 
freeze-concentration profile and how the polarized concentration of different solutes affects 
protein stability during freezing in 1 L polycarbonate bottles. We investigated the freeze-
concentration profiles of lactate dehydrogenase (LDH) solutions in 10 mM phosphate buffer, pH 
7.0, with or without sucrose and compared with the same solutions without LDH. These solutions 
were frozen at -30 °C and at different freezing rates and the contents of each bottle were evenly 
sliced into 125 cubes. Forty-five representative samples from specified locations were analyzed 
for solute concentrations and LDH critical quality attributes. A homogeneity score was devised to 
describe the overall homogeneity of the frozen bulk after freezing. In general, the solutes (i.e., 
LDH, phosphate, and sucrose) concentrated towards the center and bottom of the bottles during 
freezing, leaving the peripheral and top regions with significantly fewer solutes. The homogeneity 
of solute distribution in the frozen matrix was highly dependent upon, and positively correlated 
with, the freezing rate with significant retention of LDH activity and tetrameric native structures 
observed at higher freezing rates. Lastly, multivariate linear regression modeling showed that 
freezing rate, sample location inside the bottle, and presence of sucrose all have significant impact 
on LDH stability, which provided insights into the stability of other proteins during bulk freezing. 
 








Biotherapeutic bulk drug substances are typically stored frozen 1, which allows for 
operational flexibility for fill and finish of drug products and extends the shelf life of protein 
solutions 2,3. When proteins are stored frozen, the rates of many reactions leading to physical and 
chemical degradation are reduced 4. Also, freezing of protein solutions minimizes the possibility 
of microbial growth and eliminates foaming during transportation 5. However, despite several 
advantages over liquid storage, freezing stress can often destabilize proteins 6,7. Such stressors 
include: pH variation arising from preferential crystallization of buffer species 8,9; progressive 
freeze-concentration of solutes in the remaining unfrozen solution 3,10; protein structural 
perturbation at ice-aqueous interfaces 11; and phase separation mainly due to the formation of 
multiple amorphous phases or crystallization of solutes 12–15. These stressors can lead to 
perturbation of native protein structure, often resulting in protein aggregation 16 which not only 
can impair the activity of the drug, but also may induce immunogenic responses 17. It is, therefore, 
necessary to thoroughly understand the freezing process and its impact on protein stability to 
minimize product quality change during processing 14. 
The freezing process of aqueous solutions is characterized by a first-order phase transition 
resulting in ice crystallization from supercooled water 18. Temperature change over time during 
freezing of a sucrose solution is displayed in Figure 1. The first thermal event involves cooling of 
the solution to the supercooled state (Figure 1, point A to B) 19. Supercooling occurs when a liquid 
is cooled below its equilibrium freezing temperature without becoming a solid, with temperatures 
of 10-15 °C below the freezing temperature typically achieved 19,20. Once ice nucleation occurs, 
ice crystal formation and growth proceeds by the addition of water molecules at the ice-liquid 






the equilibrium freezing point (Figure 1, point B to D). Even though heat is constantly being 
removed from the solution by the cool air circulating inside the freezer, the temperature plateau is 
explanained by the release of latent heat during ice formation. The horizontal portion of the 
freezing temperature profile (Figure 1, point C to D) represents the phase transition of water, and 
the time elapsed during the phase transition can be defined as the freezing time 13. Following the 
completion of the  phase transition, the temperature again begins to drop until it reached the freezer 
temperature (Figure 1, point D to E) 21, resulting in a eutectic solid or a maximally freeze-
concentrated matrix. Crystallizing solutes, such as sodium chloride 15, mannitol 23, and certain 
buffer salts 9, will go through a eutectic point and crystallize. Proteins, in general, do not crystallize 
during freezing but are vitrified into rigid amorphous solids at the glass transition temperature 
(Tg`) 24, sucrose behaves in a similar way. The glass transition process is a reversible change 
between a viscous liquid and a rigid glass system 21,25. Optimal storage conditions are below the 
Tg` of the formulation at which molecular mobility is very restricted and degradation rates are 
correspondingly slow 20. 
The rate of freezing, which is defined as the ratio of the change in product temperature to the 
required freezing time, can affect protein stability 19,22. Increasing the  rate minimizes the residence 
time of labile proteins in the freeze-concentrated reactive environment 26 and limits the kinetic 
processes leading to phase separation 26. The rate of freezing, by influencing the extent of liquid 
supercooling, also determines the size and morphology of the ice crystals formed, with increases 
in the freezing rate favoring the formation of ice protuberances known as ‘dendrites’ 6. Formation 
of dendritic ice structures is considered desirable as it favors protein stability 27–29 by entrapping 







In contrast, slow freezing, particularly at large scales has the potential to generate high 
heterogeneity in solute distribution 24. Solutes, including proteins, are typically excluded from the 
growing ice crystals during freezing 30. When a solution is slowly frozen, ample time is provided 
for transport of solute molecules away from the slowly- moving ice before they can become trapped 
in the newly formed ice crystals, leading to solution heterogeneity as the solute concentration 
continuously increases in the unfrozen portion of the solution 6. This phenomenon is known as 
freeze-concentration or cryoconcentration, favors protein degradation 13,29 by increasing the 
probability of molecular collisions that can lead to protein aggregation or precipitation 3,7. 
Moreover, changes in pH and ionic strength, which may arise from the crystallization of certain 
solutes upon supersaturation as temperature decreases, may favor formation of non-native protein 
aggregates 6,10. In addition, freeze-concentration may accelerate the rates of certain second-order 
chemical reactions 31, as well as increase the thermodynamic driving force for phase separation in 
the unfrozen liquid. For instance, the formation of multiple amorphous phases has been reported 
for protein:polysaccharides systems during the freezing step of a lyophilization cycle 10,32, which 
can deprive the protein from the stabilization effect provided by saccharides.  
The majority of published research on freezing of therapeutic proteins focuses on the effect 
of formulation (e.g., pH, ionic strength, buffer composition, and selection of cryoprotectant) on 
protein stability 33, but very few have studied the effect of the freezing conditions 6,34–37 or solution 
volume, with most studies conducted on small volumes (e.g.,  2–4 mL volumes). Freezing studies 
conducted with low solution volumes are not capable of revealing the formation of temperature 
and solute concentration gradients that occur during freezing and are best studied at larger volumes 
(i.e., ≥ 1 L) 34, which also allow for determination of solute distribution within the frozen volume 






microenvironment which changes with time. The current study systematically evaluates the impact 
of freezing rate on freeze-concentration of a single excipient, alone or in a solution with multiple 
excipients, on the stability of a model protein solution, L-lactate dehydrogenase (LDH), in 1 L 
bottles.  A novel methodology was designed to measure the spatial 3D distribution of solutes and 
to quantify protein quality attributes at different regions in the frozen volume. An assessment of 
solution homogeneity, or “homogeneity-score,” was devised to quantify the  extent of solute 
freeze-concentration, for the purpose of comparing the homogeneity/heterogeneity of different 
formulations after freezing, and relating it to the degradation of the model protein.  
 
4.4 MATERIALS AND METHODS 
4.4.1 Materials 
L-Lactate dehydrogenase (LDH) ammonium sulfate suspension from rabbit muscle and 
analytical grade sucrose were purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). Sodium 
phosphate monobasic and sodium phosphate dibasic were obtained from JT Baker (Center Valley, 
PA, USA). 
 
4.4.2 Solution preparation  
LDH suspension was dialyzed against 10 mM sodium phosphate buffer, pH 7.0, at 5 °C 
overnight before use. All protein formulations contained 0.5 mg/mL LDH and 10 mM phosphate 
buffer, pH 7.0, with or without 2.5 % (w/v) sucrose. Three placebo solutions were also used in the 
study: (a) 2.5 % (w/v) sucrose, (b) 10 mM phosphate buffer, pH 7.0, and (c) 2.5 % (w/v) sucrose, 







4.4.3 Freezing process and frozen state sampling  
Each solution was filled into a 1 L square polycarbonate bottle (600 mL fill), individually 
loaded into the freezer at -30 °C and allowed to freeze over the course of 24 hours. The freezing 
process was conducted either in a regular freezer (“RF”; 10834-034, VWR, Philadelphia, PA, 
USA) or in a blast freezer (“BF”; XBF40D, Thermo Fisher Scientific, Asheville, NC, USA). After 
24 hours and upon confirmation that the bulk solutions were completely frozen, the contents of the 
bottle were sampled and analyzed as described below.  
On top of a pre-cooled granite board, each bottle and frozen solution was axially cut into 
five even slices, using a power saw with a pre-cooled blade (r3031, Ridgid Thru Cool, St Elyria, 
OH, USA). Each one of these slices (approximately 1.8 cm in thickness) were subsequently 
divided into five even columns and, finally, each column was sliced into five even rows, yielding 
a total of 125 sample cubes (approximately 4.8 mL each) per bottle of frozen solution. Each cube 
was labelled with a 3-digit number indicating its spatial location in the frozen bulk. Afterwards, 
45 representative samples per bottle were chosen (Figure 2), individually thawed at room 
temperature, and individually filtered through a 0.22 µm filter. All 45 samples were analyzed for 
the concentration of solutes and pH. Solutions containing LDH were also analyzed for the 
percentage of low molecular weight species (%LMW) and LDH enzymatic activity, as protein 
stability indicators.  
 
4.4.4 Solutes concentration analysis  
Phosphate concentration was indirectly determined from the conductivity measurements 
using a pH/conductivity meter (S470 SevenExcellence™, Mettler Toledo, Cheung Sha Wan, 






measuring osmolality using a vapor pressure osmometer (model 5600, Wescor, Logan, UT, USA), 
where the osmolality contribution of phosphate was considered negligible. LDH concentration was 
determined from the absorbance at 280 nm by a SoloVPE UV/Vis Spectrophotometer (C 
Technologies, Inc., Bridgewater, NJ, USA) using an extinction coefficient of 1.44 mL mg-1 cm-1 
38. 
It is important to note, however, that only the state diagram of each system gives the actual 
concentration of the maximally freeze-concentrated matrix (FCM) trapped into micron-sized 
spaces between ice crystals. This microscopic freeze-concentration is based on the unavoidable 
dehydration of the amorphous phase when water molecules turn into ice crystals 41. And, as ice 
crystallization progresses, the theoretical maximal freeze-concentration could be obtained 
regardless of the sample position within the bulk and processing conditions 42. Also, the analyzed 
ice-cored samples were composed of FCM as well as ice crystals. When thawed before analysis, 
the pure ice fraction diluted the FCM fraction. Hence, the sampling method employed here does 
not provide the true concentration of the FCM of the amorphous phase. Instead, the main focus of 
this work is on progressive freeze-concentration occurring  on a macroscopic scale 43, which should 
be interpreted as the FCM content varying with position within the frozen bulk. 
 
4.4.5 Assessment of LDH stability  
The activity of LDH was determined using a LDH activity assay kit (Sigma-Aldrich Co., 
St. Louis, MO, USA), with which LDH catalyzes the reduction of NAD to NADH, which is 
specifically detected by a colorimetric (450 nm) assay. For each sample, the enzymatic activities 
are reported as the means of 3 determinations, normalized by the LDH concentration in each 






determined prior to freezing. Size exclusion chromatography (SEC) was used to determine the 
extent of soluble protein aggregates and low molecular weight species formed after freezing. 
Analyses were performed on a Waters Acquity UPLC system using Empower 3 software® (Waters 
Corporation, 2010). Samples were separated on an Acquity UPLC® Protein BEH SEC column 
(Waters Corporation, Milford, MA, USA). The mobile phase was 10 mM phosphate buffer with 
500 mM sodium chloride at pH 7.0, delivered isocratically at 0.4 mL/min. Elution was recorded 
on a diode array UV detector, and calculations were based on 280 nm chromatograms. %LMW 
relative to the initial values before freezing was reported as the sole result because no significant 
changes in percentage of high molecular weight species were observed in this study. 
 
4.4.6 Freezing temperature profiles 
In addition to the contents of the frozen bottles, which were sliced and analyzed, duplicate 
bottles with the solutions were frozen with eight type T thermocouples placed in different locations 
within the bottle to monitor temperature changes during freezing (Figure 2c). Three sensors were 
fixed next to the container wall, at the top, middle, and bottom positions; and another five 
thermocouples were placed at the radial center of the bottle, at heights corresponding to each one 
of the five axial slices. All temperature profiles were recorded with a Data Logger 
(OMEGAHH147U, Newport ElectronicsGmbH, Deckenpfronn, Germany).  
The freezing time at each location, the time when the solution surrounding the tip of the 
thermocouple becomes frozen, was defined and standardized as the time elapsed from the 
beginning of the phase transition to when the temperature decreased to -4 °C 39, below the freezing 








A homogeneity score (H-Score) was created and defined according to equation 1 to 
quantify the homogeneity of solute distribution post-freezing. H-Scores were calculated for each 
solute in each bottle.   
𝐻𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦 𝑆𝑐𝑜𝑟𝑒 = 1 − (
𝑀𝐴𝐷 (𝑋)
𝑀𝑒𝑑𝑖𝑎𝑛 (𝑋)
)                                     (1) 
where X represents the sample of direct or indirect concentration measurements for a particular 
solute and bottle, and MAD is the median absolute deviation around the median of measurements, 
as defined by equation 2. 
𝑀𝐴𝐷 = 𝑚𝑒𝑑𝑖𝑎𝑛 (|𝑋𝑖 − 𝑚𝑒𝑑𝑖𝑎𝑛 (𝑋)|) ; i = 1, …, 45                                (2) 
where Xi is the i
th representative sample block of the bottle. The H-Score may take on values in the 
interval, (0, 1]. For a perfectly homogenized system, the variability in concentration measurements 
across all representative sample cubes of the bottle is zero, and the H-Score = 1; a perfectly 
homogeneous system will result in a computed H-Score of exactually 1; H-Score less than 1 
signifies that the system is heterogeneous, with lower H-Scores indicating a higher degree of 
heterogeneity.  
 
4.4.8 Statistical evaluation and modeling of the results 
JMP® 13.0 (SAS Institute Inc, New York, NY, USA) was used for statistical evaluation of 
the data. A significance level of 0.05 was applied throughout the analysis. Using linear least 
squares regression, the responses (i.e., % initial LDH activity, normalized % LMW species, and 
normalized LDH concentration) were modeled against the main effects of the freezing method, 
distance from the bottom of the container (DB), distance of each axial layer to the center of the 






interactions. Quadratic terms for the DB and DLC factors were also included in the models. Outlier 
analysis was performed on the initial model using a studentized residuals test with a threshold of 
±2.575. Model validity was assessed from the adjusted R2 and RMSE.  
 
4.5 RESULTS 
4.5.1 Solution temperature profile during freezing 
In order to profile the heterogenous microenvironment inside a frozen solution and 
determine the underlying causes of the heterogeneity, the temperature change over time at different 
locations inside one bottle was first monitored. Eight thermocouples (Tc) were positioned at 
various representative locations inside the solution as illustrated in Figure 3c. Figure 3 shows the 
temperature profiles and the freezing time at each monitored location when the bottle of solution 
was placed inside a -30 °C RF or a -30 °C BF.  
The temperature change over time recorded in different parts of the bottle indicated how 
freezing progressed. During both freezing processes, the peripheral locations exhibited shorter 
freezing times than the center locations, indicating a centripetal direction of freezing. At the center 
3rd layer (geometrical center), the liquid cooled more slowly than the liquid at the bottom and top 
center positions, revealing the axial freezing direction towards the middle of the container. 
Consequently, the geometrical center of the solution took the longest time to complete phase 
transition, indicating that it was the last region to freeze in both regular and blast freezing 
conditions. Therefore, throughout this study, the freezing time representing the entire solution was 
defined as the freezing time of the geometrical center, which was determined from the Tc data. 
As represented by the dashed lines in the temperature profile (Figure 3a), the solution 






times of 3.1 hours and 5.8 hours, respectively. This was because the blast freezer generates forced 
air convection current through an internal fan resulting in a 47% faster freezing process compared 
to the stagnant-air freezing process in the regular freezer.  
Using the same method as above, a total of five different solutions were frozen in both RF 
and BF, with their freezing times monitored (Table 2). As seen previously, blast freezing times 
were shorter and approximately 40% to 50% less than those required by regular freezing.  
 
4.5.2 Impact of freezing rate on LDH stability after two freeze-thaw cycles   
In order to evaluate the impact of freezing rate on the overall stability of LDH, two bottles 
of the LDH+buffer solution were frozen in either RF or BF and thawed under the same condition. 
The same F/T cycle was repeated once for a total of two cycles. Samples were taken after the 
thawed solutions were homogenized and subjected to SEC and LDH activity tests (Figure 4).  
The evaluation of the homogenized solution post F/T represented the average protein 
degradation throughout the entire bulk. Overall, LDH activity decreased after each F/T cycle while 
the pertentage of LMW species increased, which indicated that F/T cycles caused dissociation of 
LDH tetramers, contributing to the loss of protein activity. Moreover, the solution frozen in the 
blast freezer achieved better protein stability, suggesting that a freezing rate 40-50% higher than 
that achieved by RF may help to maintain protein stability during the bulk freezing process.   
 
4.5.3 3D profiles of solutes distribution following freeze-concentration  
Ice formation during bulk-scale freezing often leads to progressive freeze-concentration of 
solutes resulting in heterogeneous protein distribution throughout the bottle. Such heterogeneity 






microenvironment 40. But in a typical F/T study or in a long-term frozen storage study, a sample 
is taken after homogenizing the solution post-thawing (Figure 4) and it is therefore not possible to 
assess heterogeneity in distribution. For proteins that are prone to aggregation or dissociation, this 
may lead to an erroneous conclusion that a particular formulation is unstable following F/T or at a 
particular storage temperature, while optimizing the F/T process may be overlooked.  
In this study, a frozen solution of 600 mL in a 1 L square bottle was evenly cut into 125 
cubes in order to obtain a reasonably detailed 3D profile of the solute distribution. Forty-five 
representative samples from different locations were chosen and thawed individually. After 
homogenization of each individual sample, the content of each sample was analyzed, which 
represented an average volume of approximately 4.8 mL taken from one of the 125 sampled 
locations in the frozen bulk solution. Sucrose, phosphate buffer, and sucrose+phosphate buffer 
solutions were each frozen in a regular or blast freezer and processed using this method. Sucrose 
and phosphate concentrations in each sample were obtained and profiled as a function of location 
in the frozen solution (Figure 5).  
Overall, solutes distributed more evenly post-blast-freezing compared to post-regular- 
freezing. For instance, in the 2.5% (w/v)  sucrose solution, sucrose concentrations varied from 
0.8% to 5.5% after regular freezing, but 1.0% to 3.9% after blast freezing. Among the three 
solutions shown in Figure 5, the maximum difference in the solute concentration varied by more 
than 6-fold after regular freezing, but less than 3.9-fold after blast freezing.  
In addition, solutes concentrated towards the centers and bottoms of the bottles after 
freezing, leaving the peripherial and top regions with significantly less solutes. The most 
concentrated samples were found at the center of either of the bottom two layers, not at the 






while density of the unfrozen liquid was gradually increasing during freeze-concentration.  
In order to further characterize the heterogeneity of solute distribution in the frozen mass, 
we created the homogeneity score (Equations 1 and 2) and calculated the scores for each solute in 
all three solutions using the solute concentration determined in each of the 45 ice-cored samples 
from each bottle (Table 3).  
According to equation 1, the smaller the median absolute deviation is in a data set, the more 
homogeneous the solute distribution will be. In the case of a perfectly homogeneous solution, all 
samples are identical and therefore, the median absolute deviation is 0 and the corresponding H-
Score is 1. Faster freezing by blast freezing led to a higher H-Score for both solutes in each of the 
three placebo solutions. The calculated H-Score corroborated with the 3D scatterplots which 
showed that higher freezing rates resulted in more homogeneous solute distributions.  
The same method, as described above, was used to study two different LDH-containing 
solutions. 3D profiles of LDH concentration, osmolality, and conductivity changes post-freezing 
were generated (Figures 6, 7 and 8). In this instance, the osmolality and conductivity were chosen 
to compare the overall contents of solutes as functions of sample location in the bottle; because 
LDH and its subunits’ contribution to both osmolality and conductivity could not be neglected to 
determine individual concentrations during calculation. 
As seen for the placebo solutions, blast freezing led to more homogeneous solute 
distribution than did regular freezing. The highest LDH concentration and/or solute content were 
also found at the center of one of the two bottom layers, while the lowest was found along the four 
edges. Thus, there was a fair correlation between the previously determined last points to freeze 
and the areas of highest concentration of solutes, confirming protein exclusion from ice crystals 






points to freeze in the bulk solution. 
The solute distribution profiles in the frozen matrix were highly dependent on the freezing 
rate. For instance, for the LDH+buffer+sucrose solution, the osmolality ranged from 0.21 to 3.5 
times the initial osmolality after regular freezing; narrowing to 0.47-2.8 times that of initial 
osmolality after blast freezing. Solutes which were excluded from the ice structure during ice 
crystal formation were progressively transported by diffusion and convection towards the centers 
and bottoms of the containers 6. The slow freezing process favored solute transport due to longer 
freezing time and fewer ice dendrite formation 6. 
Similar to the placebo solutions, homogeneity scores were also calculated for LDH-
containing solutions, with faster freezing again resulting in more homogeneous solute distribution. 
Table 4 shows that protein formulations containing sucrose minimized freeze-concentration 
(increased the homogeneity scores) at slower freezing rates. Addition of sucrose would be 
anticipated to increase the solution viscosity, resulting in slower diffusion rates and solute mass 
transfer 39. 
 
4.5.4 Amorphous phase separation upon progressive freeze-concentration of solutes  
Following freezing, the relative changes in osmolality and conductivity were greater than 
the corresponding LDH concentration under both freezing conditions. For example, following 
regular freezing of LDH+buffer+sucrose solution, on average, ice-cored samples close to the outer 
edges and at the top layer exhibited on average 45% of the initial protein concentration, but only 
36% of the initial osmolality. In comparison, samples at the center and bottom positions showed 
only 174% of the initial protein concentration but 265% of the initial osmolality. Sucrose can be 






source of conductivity. Both of these solutes have markedly lower molecular weights compared to 
LDH. Therefore, these distinct profiles indicate that solutes with different diffusion coefficients, a 
property which tends to decrease with respect to increasing molecular weight, may distribute 
differently during freezing.  
Table 5 shows the molar ratio of protein to stabilizer before and after freezing at distinct 
freezing rates and at ice-cored samples from the center and edge positions of the bulk solution (as 
indicated in Figure 3c). The results suggested the occurrence of phase separation between the 
protein and the stabilizer, as the ratio of LDH:sucrose changed after freezing. Upon regular 
freezing, the protein-to-sucrose ratio varied from 0.7 to 1.8 –fold the initial value determined prior 
to freezing, whereas only 1.0 to 1.3-fold variation in this ratio was observed after blast freezing. 
Overall, a higher rate of freezing imposed by the blast freezer mitigated the amorphous phase 
separation. The location of the samples within the frozen volume also influenced the protein to 
sucrose ratio. Decreased LDH: sucrose ratios were found at samples from the edge of the 
containers, whereas samples from the center of the containers ended up with increased ratios. 
 
4.5.5 Effect of freeze-concentration on LDH stability  
Samples withdrawn from the center of the containers also showed higher LDH activity 
compared to the ice-cored samples from the periphery of the bottles (Figure 9). Higher LDH 
enzymatic activity was retained at the center of one of the two bottom layers, while the lowest 
activity was found along the four edges of the bottle. In addition, the LDH activity profiles in the 
frozen matrix were highly dependent on the freezing rate. Higher homogeneity in solute 
distribution which was achieved with faster freezing (BF) further correlated with improved 






LDH+buffer solution, the LDH activity ranged between 28% and 103% of the initial activity after 
slow freezing (RF), improving to 74-156% after fast freezing (BF). 
A similar trend in stability was observed for the LMW% variability within the frozen 
material (data not shown). Increase in LMW levels was mainly observed at the top layer and 
towards the edge of the containers. The material at the center of the container showed greater 
stability, exhibiting just a slight change in the level of LMW%. Thus, there was a clear correlation 
between the previously determined areas of highest protein and excipients concentration and the 
areas within the frozen bulk which retained higher protein stability. 
The overall impact of solute freeze-concentration on LDH stability was compared between 
the same LDH solutions (with and without sucrose) frozen in the blast freezer and regular freezer 
(Figure 10). Faster freezing in the blast freezer was able to maintain LDH activity (on average, 
116% of the initial activity) with a slight increase of 0.43% in the average LMW species. On the 
contrary, slower freezing in the regular freezer resulted in only 76% of LDH activity with a 
significantly higher increase in LMW species (0.76% on average). The addition of sucrose to the 
LDH solution significantly reduced the LDH dissociation and maintained the average LDH 
activity at 100%. 
 
4.5.6 Multiple linear regression models  
Multiple linear regression was used to identify which factors (Table 1) and interactions 
have significant effects on three responses: (a) % initial LDH activity, (b) normalized % LMW 
species, and (c) normalized protein concentration. Normalized responses were obtained by 
dividing each ice-cored sample measurement by its corresponding initial measurement before 






effects, two-way interactions, and quadratic terms. The effect sizes of the predicted responses were 
compared based on a scale-invariant factor known as scaled estimate, which is centered by its 
mean and represents half of the effect size of each model factor. 
Using linear least squares regression, a significant model was obtained for % initial LDH 
activity (adjusted R2 of 0.60, RMSE of 23.07). Nine outliers out of 1,050 data points were 
identified and excluded from the model. Figure 11a shows the dependence of % initial LDH 
activity on sample position within the frozen bulk. In addition, the normalized %LMW species 
was modeled against the main effects described in Table 1. The resulting final whole model was 
statistically significant at a 0.05 significance level and yielded an overall adjusted R2 of 0.70 and 
an RMSE of 0.354. Eleven outliers out of 350 data points were identified and excluded from the 
model. The 3D surface plot for the normalized %LMW is shown in Figure 11b.  
Interactive prediction profilers detailing the variation of the mean responses with the 
investigated factors were also constructed based on the models and are shown in Figures 12 and 13 
for the percentage of initial protein activity and the normalized %LMW species, respectively. 
The multiple regression analysis identified the significant factors affecting stability of the 
protein during the freezing process. The most significant factor settings (p-value ≤  0.05 and largest 
effect size) that were detrimental to protein stability were slow freezing (RF); location, specifically 
positions farther away from the bottom and radial center of the containers; and lack of 
cryoprotectant (sucrose = N). Overall, increasing the sample distance from the container bottom 
(DB) and increasing the distance at each layer from its radial center (DLC) resulted in significant 
loss of protein activity and tetramer purity, as it induced the dissociation of the native LDH into 
low molecular weight species. 






samples closer to the center-bottom within the frozen volume. Also, blast freezing significantly 
avoided extensive formation of LMW species after freezing, in all positions within the bottle. 
Moreover, samples at the top layer and edge regions within the containers showed significant 
higher dissociation of LDH multimeric protein into LMW (Fig 13c and d) when compared to the 
rest of the bulk. 
 
4.6 DISCUSSION 
In this series of studies, we quantified the extent of macroscopic freeze-concentration of 
solutes and its corresponding impact on LDH stability. The overall freezing behavior and 
concentration changes in the solid phase were characterized in 1 L containers for two distinct 
freezing rates. Lastly, the LDH stability was assayed and correlated with the respective freezing 
profile, solutes freeze-concentration extent, and position of the ice-cored sample within the bulk. 
 
4.6.1 Freezing time and direction of freezing 
The freezing process started by cooling the solution down to its transition temperature. 
Spontaneous nucleation occurred at 0 to -2.6 °C. For the solutions frozen in the blast freezer, the 
liquid closer to the container walls exhibited small supercooling followed by a freeze exotherm. 
While supercooling is frequently observed in small-scale systems, it is rarely seen in large-scale 
systems 45, as is reflected in the data (Figure 3a). For the solutions frozen in both regular and blast 
freezers, the liquid solution at the center of the containers did not show evidence of supercooling 
prior to ice crystal nucleation and growth, same for the edge positions during regular freezing. 
Phase transition occurred at approximately 0 °C and varied in duration depending on the sample 






dropped toward and reached the ambient freezer temperature.  
The higher freezing rate achieved with BF correlated with a higher degree of supercooling 
resulting in a more rapid phase change. Moreover, the forced cool-air convection inside the blast 
freezer efficiently removed the heat released during solidification, leading to shorter freezing times 
compared to the regular stagnant-air freezing process, as shown in Figure 3. 
The freezing rate can be calculated by dividing the temperature gradient by the time 
interval. The calculated rates of freezing in the geometrical center position were found to be −0.06 
and −0.11 °C/min, after regular and blast freezing of the LDH+buffer+sucrose solution, 
respectively. On the other hand, the freezing rates at the edge of the same solution were found to 
be −0.09 and −0.27 °C/min, after regular and blast freezing, respectively. Hence, edge positions 
near the heat transfer surfaces were the first to freeze, followed by the liquid at the bottom and top 
layers. The longest time to freeze was observed at the geometrical center position. The dimensions 
of containers used to freeze drug substances and the material distance from the actively cooled 
surfaces have a major impact on freezing times and evolution profile 46. For instance, Lashmar et 
al. 39 found a ten-fold increase in freezing times with only a three-fold greater freezing distance.  
 
4.6.2 Bulk scale freeze-concentration of solutes 
The ice-cored samples from 1 L bottles were analyzed for macroscopic freeze-
concentration of solutes. The degree of solute freeze-concentration was clearly influenced by the 
freezing rate and the sample position within the bulk (Figures 5-8). 
Overall, the results from extensively sampled frozen bottles showed highest solutes 
concentration towards the center positions inside the containers. The solutes concentration 






increase in protein concentration at specified ice-cored samples compared with the initial 
concentration after both regular and blast freezing at -30 °C. Osmolality increased 3.5-fold after 
regular freezing and 2.8-fold at central radial positions after blast freezing. In contrast, samples at 
edge positions were mostly depleted of solutes. The solute concentration measured at edge 
positions were lower compared with center positions for all five vertical layers. There was a 2.8-
fold decrease in protein concentration after regular freezing and 1.4-fold decrease after blast 
freezing. Osmolality measured at edge ice-cored samples decreased 4.8-fold after regular freezing 
and 2.1-fold after blast freezing. This observation is consistent with previous studies on bulk 
freeze-concentration 46,47. Webb et al. 41 investigated freeze-concentration in 1 L bottles for 1 
mg/mL bovine serum albumin solutions and reported 4.6-fold and more than 8-fold increases in 
protein concentrations, compared with initial solution concentrations, after freezing at -80 °C and 
-20 °C, respectively, with the regions exhibiting a higher degree of freeze-concentration observed 
near the bottom-centers of the bottles. Similarly, Lashmar et al. 39 reported a 9.3-fold increase in 
protein concentration (starting concentration was 0.8 mg/mL) and a 7-fold increase in osmolality 
at the last point to freeze inside 20 L carboys.  
One possible explanation for these solute concentration profiles is the density increase of 
the remaining liquid phase that occurs at the onset of ice formation. As the solutes increase in 
concentration immediately adjacent to the ice front, the density of the unfrozen solution increases, 
which triggers natural convection flow. These flow patterns generate axial gradients leading to 
solute transport towards the bottom and center of the container 6. In addition, heat transfer occurs 
predominantly through the outer bottle surfaces, which may have contributed to the concentric 
pattern of the solutes concentration gradients. Table 6 compares the effects of both freezing 






throughout the frozen bulk solution. The relative distance of the sample from the bottom of the 
container had the greatest bearing on LDH redistribution in the bulk solution.  
The approximately 50% lower freezing rate observed during regular freezer, compared to 
the blast freezing, resulted in a higher degree of redistribution of solutes concentration. Slow 
freezing caused approximately 6.1-fold variation in protein concentration within the container, 
with certain areas containing only 36% of the initial protein concentration. In contrast, fast 
freezing, which mitigates redistribution of the protein molecules throughout the frozen bulk 
solution (approximately 3.7-fold variation), was correlated with higher homogeneity scores. In 
general agreement with the results reported here, Maity et al. 35 observed approximately 2-fold 
cryoconcentration in the center-bottom positions in 2 L bottles frozen at -80°C, with no relevant 
cryoconcentration observed following ‘‘flash’’ freezing with liquid nitrogen.  
Efficient removal of latent heat is an important factor to consider during bulk freezing. The 
cold air stream in the blast freezer efficiently removed the heat generated during solution 
solidification which resulted in faster cooling and more homogeneous solutes distribution within 
the frozen solution. Ultimately, the final concentration profile of solutes in the ice will be 
determined by the relative rates of solutes transport during freezing of the bulk solution, which is 
correlated with the convection patterns and the rate of growth of the ice front 6,8,29. For the same 
container dimensions, the ice front grew more rapidly at the higher heat-transfer rate imposed by 
the blast freezer. In such conditions, the ice growth rate exceeded the solute mass transfer rate, 
resulting in solutes entrapment within the ice domains and more homogeneous solutes distribution 
throughout the frozen bulk solution.  
The macroscopic freeze-concentration behavior shown in Figures 5–8 and the 






are also related to the ice morphology. The formation of ice dendrites is thought to reduce the 
extent of freeze-concentration because these ice protuberances can inhibit both diffusion and 
convection of solutes in the inter-dendritic spaces 29. The formation of ice dendrites was previously 
characterized in terms of the linear ice front velocity 6. The higher ice-front velocity achieved 
during faster freezing favors the growth of ice dendritic structures. Butler 27 observed a planar ice 
front developed for ice front velocities slower than 2 μm/s for BSA and sucrose solutions, whereas 
dendritic structures were found at velocities above this value. 
 
4.6.3 Impact of bulk freeze-thaw and polarization of solutes concentration on LDH stability  
Bulk-scale freeze-concentration results in exposure of protein molecules to high 
concentrations of solutes. Bearing in mind that protein degradation increases with time, and 
typically increase with at least the square of protein concentration 48, protein stability was then 
investigated for samples aliquoted before and after freezing. In each case, the enzymatic activity 
and the quaternary structure of LDH were examined, because the fully assembled LDH tetrameric 
structure has been reported to dissociate into less active monomers and dimers during freezing 
38,53.  
The present study showed that at a fixed thawing rate, the highest recovery of enzymatic 
activity was observed after fast freezing (at about 0.11 °C/min), with lower activity observed 
following thawing of samples that had been frozen more slowly (0.06 °C/min) (Figure 4). Also, 
the maintenance of LDH quaternary structure during freezing correlated well with enzyme activity 
determined after F/T cycles. Section 3.5 summarizes the statistically significant factors influencing 
LDH stability after freezing. A low freezing rate (RF) and position of sample close to the edge of 






Bulk freezing in 1 L bottles was found to generate extensive solutes redistribution, which 
was further verified to negatively affect the LDH quality attributes. The observed changes in the 
physical and chemical microenvironments surrounding LDH molecules may lead to dehydration, 
aggregation, or dissociation of proteins, all of which can cause loss of enzymatic activity 49. Faster 
freezing substantially reduces solutes macroscopic freeze-concentration (confirmed by higher 
corresponding homogeneity scores) which is correlated with reduced LDH denaturation. 
Conversely, slow freezing led to substantial solutes macroscopic freeze-concentration (lower 
homogeneity scores) and significant loss of protein activity (only 76% of the initial LDH activity, 
on average). The freezing rate is known to affect the morphology and size of ice crystals and to 
change local physicochemical properties, such as pH and solutes concentration 50. Thus, 
pronounced freezing-induced stresses such as pH shift and phase separation 49 may have 
contributed to the lower protein stability following lower freezing rate. Moreover, the time of 
exposure to the highly reactive freeze-concentrated environment is extended by the freezing time 
(approximately 3.0 hours following blast freezing, compared to approximately 5.7 hours following 
regular freezing).  
Improved protein stability correlated well with frozen microenvironments rich in protein 
content. The increased retention of activity of multimeric proteins such as LDH with increasing 
concentration during F/T has long been recognized 50–52. Cao et al. 50 observed significant LDH 
activity loss at low concentrations, and activity recovery was increased with the increase of enzyme 
concentration. The activity recovery was nearly 100% for solutions with 1 mg/ml concentration 
and only 75% at 0.20 mg/mL. This dependence of LDH activity on concentration can explain the 
wide range in LDH activity observed in this study, as the activity assay employed ice-cored 






Furthermore, we noted the dissociation and loss of LDH activity in a sodium phosphate 
buffer system, in which acidification is known to occur during freezing. The crystallization of the 
disodium salt (Na2HPO4) during freezing can produce a pH drop and which may have contributed 
to the freeze denaturation of the LDH, which is a pH-sensitive assembly 53. It was observed that 
the pH of sodium phosphate solutions could drop more than three units depending on the freezing 
conditions applied 8,54,55. Thus, mechanistic explanations for the loss in LDH stability during 
freezing could also be related to potential salt precipitation and pH shift, particularly at freezing 
rates below 1 °C/min, as observed by Cao et al. 50. When freezing rates are sufficiently slow, it is 
likely that chemical and thermodynamic equilibrium is achieved, leading to maximum salt 
precipitation and pH change. 
Formulations containing sucrose also showed enhanced protein stability after freezing. It 
has been reported that a protective effect, especially at low protein concentrations, can be achieved 
by the addition of polymers and sugars which are preferentially excluded from the surfaces of 
proteins and increase the overall thermodynamic stability of the native protein 53. Anchordoquy et 
al. 38, reported that the presence of sucrose inhibited LDH dissociation during freezing, which in 
turn resulted in maintenance of native quaternary structure and improved recovery of LDH 
activity. Presence of sucrose aids the formation of a glassy matrix with sufficiently high viscosity 
to appreciably reduce molecular mobility. The consequent lack of molecular mobility potentially 
contributed to the reduced LDH dissociation observed at LDH+buffer+sucrose solutions. 
The stabilizing effect of sucrose can be compromised, however, if freeze-concentration 
leads to phase separation of the formulation components. In this regard, our findings suggest 
amorphous phase separation between sucrose and protein molecules. Sucrose was depleted to a 






weight, sucrose diffused more efficiently and accumulated at the last positions to freeze in greater 
abundance than the protein molecules. The steeper concentration gradient for sucrose can be a 
result of the higher diffusion coefficients for smaller sugar molecules compared to proteins 
macromolecules. In a previous study 41, sodium citrate concentrations consistently increased to a 
greater extent than the larger BSA molecule in some regions of the bulk solution after freezing. 
A rapidly advancing ice front is critical to entrap solute molecules uniformly and to prevent 
prolonged freeze-concentration stress in the protein solution. This study showed that a faster 
freezing rate resulted in greater homogeneity, maintained higher LDH activity, and reduced the 
LDH tetramer dissociation during freezing. The freezing rate can, therefore, influence the degree 
of heterogeneity in frozen protein systems, which can in turn affect protein stability. Thus, faster 
freezing, which can be achieved by blast freezers, not only can reduce manufacturing time but can 
also help to maintain the drug product quality.  
 
4.7 CONCLUSIONS 
The macroscopic freeze-concentration of solutes is a common consequence of uncontrolled 
large-scale freezing. In addition to extensive solutes redistribution occurring during bulk freezing, 
our results also suggested the occurrence of amorphous phase separation between the model 
protein and excipients (sucrose and phosphate buffer salts), with negative implications for protein 
stability. In the present study, blast freezing resulted in a higher freezing rate compared to a 
conventional, stagnant-air freezer and mitigated the extent of solutes concentration polarization 
within 1 L bottles. Higher freezing rates also minimized adverse effects due to freezing on the 
studied model protein and thus would be preferred to avoid protein chemical and physical 






on the specific degradation pathway and formulation for each protein. As a general guideline, an 
appropriate freezing rate should mitigate the formation of ice-aqueous interfaces without causing 
extensive macroscopic freeze-concentration of solutes 41. 
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BF – blast freezer  
DB – distance from the bottom of the container  
DLC – distance of each axial layer to the center of the container 
FCM – freeze-concentrated matrix  
F/T – freeze-thaw 
H-Score – homogeneity score 
LDH – L-lactate dehydrogenase 
LMW% – percentage of low molecular weight species 
RF – regular freezer 
RMSE – root mean square error  
SEC – size exclusion chromatography 
Tc – thermocouple 














Factor Model Designation Modeling type Levels 
Freezing method Freezing method Categorical RF, BF 
Presence of Sucrose  Sucrose Categorical Yes, No 
Distance from bottom DB Continuous Ranging from zero to 2.93 in. 






Table 2. Freezing times calculated for five solutions frozen in either the regular freezer or the blast 
freezer. 
   Freezing time (h)* 
Solutions Composition RF BF 
Sucrose 2.5 % (w/v) sucrose 5.6 2.8 
Buffer 10 mM sodium phosphate buffer, pH 7.0 5.5 2.8 
Sucrose + buffer 2.5 % (w/v) sucrose, 10 mM sodium phosphate buffer, pH 7.0 5.5 2.9 
LDH + buffer  0.5 mg/mL LDH, 10 mM sodium phosphate buffer, pH 7.0 5.9 3.4 
LDH + buffer + 
sucrose 
0.5 mg/mL LDH, 10 mM sodium phosphate buffer, pH 7.0, 
2.5 % (w/v) sucrose 
5.8 3.1 













Table 3. Homogeneity score (H-Score) of placebo solutions frozen at distinct freezing rates. 
Placebo solution Freezing method Freezing rate Sucrose H-Score Phosphate H-Score 
Phosphate buffer 
RF slow - 0.553 
BF fast - 0.817 
Sucrose 
RF slow 0.638 - 
BF fast 0.712 - 
Sucrose + phosphate 
buffer 
RF slow 0.746 0.717 























LDH + buffer 
RF slow 0.613 0.582 0.604 
BF fast 0.810 0.808 0.748 
LDH + buffer + 
sucrose 
RF slow 0.650 0.641 0.637 









Table 5. The ratio of protein to stabilizer post freezing at distinct freezing rates and sample 
location. The molar ratio of protein to sucrose in the LDH+buffer+sucrose solution before freezing 
was 1: 40600 






center 1st layer RF 0.009 1: 45760 
center 2nd layer RF 0.009 1: 52075 
center 3rd layer RF 0.008 1: 56403 
center 4th layer RF 0.010 1: 74128 
center 5th layer RF 0.011 1: 57571 
edge 1st layer RF 0.012 1: 28511 
edge 3rd layer RF 0.013 1: 33251 
edge 5th layer RF 0.021 1: 38180 
center 1st layer BF 0.017 1: 43063 
center 2nd layer BF 0.017 1: 52543 
center 3rd layer BF 0.016 1: 50084 
center 4th layer BF 0.019 1: 54721 
center 5th layer BF 0.020 1: 41137 
edge 1st layer BF 0.042 1: 40903 
edge 3rd layer BF 0.044 1: 40655 
edge 5th layer BF 0.048 1: 41287 
* Sucrose molar concentration was estimated from the osmolality readings, neglecting the 









Table 6. The effect size of factors on three responses.   
Effect size was calculated by the following formula: 𝐸𝑓𝑓𝑒𝑐𝑡 𝑠𝑖𝑧𝑒 = 2 × 𝑠𝑐𝑎𝑙𝑒𝑑 𝑒𝑠𝑡𝑖𝑚𝑎𝑡𝑒 
NS: non-statistically significant model effects (p > 0.05). 
 
 
Term Enzymatic activity % LMW species Protein concentration 
Freezing method[BF] 31.95 -0.43 0.10 
Freezing method[RF] -31.95 0.43 -0.10 
DB -32.84 1.34 -0.94 
DLC -29.98 0.59 -0.46 
Sucrose[No] NS -0.35 0.22 
Sucrose[Yes] NS 0.35 -0.22 
DB*Sucrose[No] NS -0.18 -0.09 
DB*Sucrose[Yes] NS 0.18 0.09 
DLC*Sucrose[No] NS -0.25 0.09 
DLC*Sucrose[Yes] NS 0.25 -0.09 
DB*DB NS -0.38 0.60 
DLC*DLC 13.20 -0.17 0.17 
DB*DLC 34.56 NS 0.43 
DB*DB*Sucrose[No] -8.12 0.21 NS 
DB*DB*Sucrose[Yes] 8.12 -0.21 NS 
Freezing method[BF]*Sucrose[No] 12.84 0.20 -0.11 
Freezing method[BF]*Sucrose[Yes] -12.84 -0.20 0.11 
Freezing method[RF]*Sucrose[No] -12.84 -0.20 0.11 
Freezing method[RF]*Sucrose[Yes] 12.84 0.20 -0.11 
Freezing method[BF]*DB -19.23 -0.27 NS 
Freezing method[RF]*DB 19.23 0.27 NS 
Freezing method[BF]*DLC -6.29 -0.14 -0.11 
Freezing method[RF]*DLC 6.29 0.14 0.11 
Freezing method[BF]*DB*DB 12.54 NS NS 








Figure 1. Temperature-time profile of a 2.5 % (w/v) sucrose solution in a -30 °C freezer showing 









Figure 2. Schematic depiction of the ice-coring procedure. Nine samples from each of the five 
vertical layers were selected for further analysis (highlighted in blue), resulting in 45 samples per 








Figure 3. Temperature profile (a) and freezing time (b) recorded by eight thermocouples at various 
positions (c) inside a solution (0.5 mg/mL LDH, 10 mM phosphate buffer, 2.5 % (w/v) sucrose, 









Figure 4. LDH activity and formation of LMW species of the homogeneized LDH+buffer solutions 
after two consecutive F/T cycles (frozen in either the regular freezer or the blast freezer and thawed 









Figure 5. Solute distribution profiles of sucrose solution, phosphate buffer, and sucrose+phosphate 
buffer (repeated) at -30 °C after regular freezing (RF) or blast freezing (BF). The darker and larger 










Figure 6. 3D profile of LDH concentration changes in the frozen bulk after regular (RF) and blast 
(BF) freezing. The initial LDH concentration was approximately 0.5 mg/mL in each bottle. The 









Figure 7. 3D profile of osmolality changes in the frozen LDH solutions after regular (RF) and blast 
(BF) freezing. The initial osmolality was approximately 95 mOsm/Kg for the LDH+buffer solution 
and 175 mOsm/Kg for the LDH+buffer+sucrose solution. The darker and larger the bubble, the 










Figure 8. 3D profile of conductivity changes in the frozen LDH solutions after regular (RF) and 
blast freezing (BF). The initial conductivity was approximately 9137 μS/cm for the LDH+buffer 
solution and 9720 μS/cm for the LDH+buffer+sucrose solution. The darker and larger the bubble, 









Figure 9. 3D profile of LDH activity changes in the frozen bulk after regular (RF) and blast 










Figure 10. Welch’s t-test analysis of (a) % initial activity and (b) change in LMW% for LDH 
solutions by the freezing method and presence of sucrose (N=no, Y=yes). Blue markers represent 





















Figure 11. Modeling of the (a) % initial LDH activity for the two LDH solutions and (b) normalized 
%LMW for the LDH+buffer solution after regular (RF) or blast freezing (BF) at varying positions 










Figure 12. Snapshots of the prediction profiler for LDH enzymatic activity at the radial center of 
the container, at three distinct heights: (a) bottom, (b) middle, (c) top of the solution; and (d) at the 
axial center and edge of the container. Values in red to the left of each y-axis represent the mean 
predicted value for each respective response; values in brackets represent the 95% confidence 









Figure 13. Snapshots of the prediction profiler for the normalized %LMW species at the radial 
center of the container, at three distinct heights: (a) bottom, (b) middle, (c) top of the solution; and 
(d) at the axial center and edge of the container. Values in red to the left of each y-axis represent 
the mean predicted value for each respective response; values in brackets represent the 95% 
























A new scale-down method was thoroughly evaluated for uncontrolled freeze-thaw of 
lactate dehydrogenase (LDH) solutions. A regular uncontrolled-rate freezer at -30 °C and static 
thawing at room temperature were used to freeze-thaw 5 L polycarbonate containers filled with 
the LDH solution. The large-scale conditions were mimicked in a 500 mL polycarbonate bottle 
using a controlled-temperature chamber. The containers were equipped with internal temperature 
probes. The scale-down method was based on equivalency of product temperature-time profile, 
which was demonstrated at several positions inside the 5 L and 500 mL containers; not only at the 
last point to freeze-or-thaw. 
The LDH quality attributes were evaluated before and after the freeze-thaw process by a 
range of analytical tests, including size exclusion chromatography (SEC), UV absorbance, LDH 
enzymatic activity assay, and microflow-imaging. The results indicated equivalent protein quality 
attributes post freeze-thaw in the 5 L container or 500 mL scale-down system. For instance, in 
both scales, the remaining LDH activity was approximately 82%, and the loss of LDH tetramers 
(SEC results) was about 1.2%. Furthermore, the scale-down model was thoroughly characterized 
based on the magnitude of destabilizing stresses to proteins upon freeze-thaw. Both freeze-
concentration of LDH and ice surface area were determined from ice-cored samples. Our findings 
indicated a similar extent of the protein freeze-concentration and equivalent ice surface area post-
freezing in the large-scale bottle and scale-down system.  
Overall, the scale-down method effectively reproduced the large-scale freeze-thaw 
process, through equivalency in temperature-time profiles, protein quality attributes, and freezing-
induced stresses. Implementation of this methodology could, therefore, represent an advantageous 






potential freeze-thaw stresses in a more cost-effective and less time-consuming manner. 
 
5.2 KEYWORDS: scale-down, freeze-thaw, bulk protein solution, protein quality 
 
5.3 INTRODUCTION 
Freeze-thaw processes are routinely applied to improve the stability of bulk protein 
solutions during development, manufacturing, and shipping 1. Bulk-scale studies are then required 
to define adequate freeze-thaw parameters to avoid adverse process effects on the quality and 
stability of proteins 2. These manufacturing-scale studies demand huge quantities of the drug 
substance, which is usually limited during the early stages of drug development. Besides, large-
scale tests are expensive, time-consuming, and can delay time-to-market 3. Thus, the present study 
aimed to develop a new scale-down method for freeze-thaw that is robust, easy to control, 
transferable from laboratory to manufacturing, and that properly addresses all the above large-
scale challenges.  
The use of large containers (≥ 1 L) during the freeze-thaw operation in manufacturing can 
introduce significant temperature gradients in the material 4,5. Larger volumes also experience 
longer processing times at suboptimal temperatures before complete solidification. The current 
literature, however, is limited to small-scale experiments (2–4 mL), which not only exhibit 
remarkably higher freeze-thaw rates but also effectively prevent the formation of temperature 
gradients 3. Consequently, only properly designed small-scale systems are able to address the 
complications created by the relatively large heat and mass transfer dimensions of large-scale 
systems 3.  






Slow freezing has the potential to generate high heterogeneity in solute distribution, especially at 
larger volumes 7. In that scenario, a slowly moving ice-water interface allows enough time for the 
transport of solutes away from the ice front. The resulting freeze-concentration of the solutes can 
lead to a shift in pH, decrease in the freezing point of the remaining solution, and phase separation 
4,6, and has been recognized as important stress fostering protein degradation during freezing 8,9. 
On the other hand, fast freezing minimizes the residence time of a labile protein in the freeze-
concentrated reactive environment. Moreover, kinetic processes leading to phase separation are 
limited by the shorter processing time 10. The rate of freezing also determines the size and 
morphology of the ice crystals formed by altering the supercooling degree of the solution 11. Thus, 
fast freezing can be equally damaging to proteins because it induces the formation of ice with a 
higher specific surface area.  
A  general strategy to develop a scale-down model is to apply the same setpoints used in 
the large-scale for the volume independent parameters, such as the freeze-thaw set temperature, 
container material and geometry; and proportionally scale-down the freeze-thaw volume-
dependent parameters, such as freezing rate, thawing rate, and surface area to volume ratio 12. A 
scale-down model mimicking the large-scale process should demonstrate equivalency in product 
temperature profile and freezing events (e.g., the extent of freeze-concentration of solutes and ice 
specific surface area). Both the temperature profile and the extent of thermal events depend on the 
rates of freeze-thaw. Therefore, the development of the scale-down methodology focused on the 
reproducibility of the freeze-thaw rates between the 500 mL and 5 L scales. The consequences of 
such superimposable freeze-thaw profiles on the quality attributes of the protein were further 
investigated to validate the scale-down method. 






formulations in small vials; scale-down development studies for freeze-thaw are still limited 3,13,14. 
The previous scale-down research relied on controlled-rate systems, such as the CryoWedge™ 
and the Sartorius-Stedim disposable bag system 14. In these systems, the product temperature-
profiles are programmed to generate similar freeze-thaw conditions to those observed in the full-
scale stainless steel vessels or disposable bags 14. An additional linear scalable freeze-thaw model 
was previously achieved by manipulating the geometry of rectangular stainless steel containers, 
resulting in unidirectional heat flow and same freezing pathlength between 1 L and 30 mL scales 
3. Although some research has been carried out on scale-down technologies, no single scale-down 
model exists for uncontrolled-rate freeze-thaw applying disposable plastic bottles; which was 
comprehensively investigated in the present study.  
Freezing is regarded as the principal factor determining the stability of proteins exposed to 
freeze-thaw unit operations 14. The stresses arising during freezing can lead to the perturbation of 
the native protein chemical, secondary, and higher-order structures necessary for biological activity 
15. Physical and chemical denaturation often result in protein aggregation 16 that not only can impair 
the activity of the drug but also induce immunogenic responses 17. However, there is very little 
scientific understanding about the potential impact of the volume scale on the extent of freezing-
induced stresses. This study, therefore, quantified the relative degree of freeze-concentration of 
solutes and ice specific surface area post-freezing in either 500 mL or 5 L polycarbonate 
containers.  
The hypothesis investigated is that equivalency in freeze-thaw rates results in similar 
stresses arising during the process; thus, equivalent bulk protein instability post freeze-thaw in 







5.4 MATERIALS AND METHODS 
5.4.1 Materials 
L-Lactate dehydrogenase (LDH) from rabbit muscle in ammonium sulfate suspension was 
purchased from Sigma-Aldrich Corp. (St. Louis, MO, USA). L-histidine monohydrochloride 
monohydrate and L-histidine were obtained from VWR International (Philadelphia, PA, USA). 
 
5.4.2 Solution preparation  
LDH suspension was dialyzed against 20 mM histidine buffer, pH 7.0, with a 3.5 K MWCO 
membrane at 4 °C for two hours twice followed by an overnight buffer exchange before use. The 
concentration of LDH was determined from UV absorbance (extinction coefficient 1.44 mL mg-1 
cm-1 at 280 nm) 18. The protein solution diluted with the 10 mM histidine buffer, pH 5.8, to a 
concentration of 0.1 mg/mL and filtered through a 0.22 µm-pore-size filter prior to freezing.  
 
5.4.3 Scale-down methodology for uncontrolled freeze-thaw process 
The LDH solution was filled into 5 L square polycarbonate bottles at 3.5 L fill volume and 
frozen at -30 °C (10834-034, VWR, Philadelphia, PA, USA). After 24 hours of uncontrolled-rate 
freezing, the single 5 L bottle was thawed on top of a wired shelf at room temperature, until the 
liquid at the geometrical center of the container achieved 18 °C. This large-scale uncontrolled 
freeze-thaw operation was scaled-down to a 500 mL system. 
The strategy to develop the scale-down method included:  (i) similarity between container 
material (polycarbonate) and geometry (square), (ii) similarity between the freezer set temperature 
(-30 °C) and thawing end-point (18 °C), (iii) similarity between the surface area to volume ratio 






temperature-time profiles across the two scales. Therefore, a 500 mL square polycarbonate bottle 
filled at its maximal fill volume was chosen to scale-down the 5 L freeze-thaw operation. A 
controlled-rate system (Tenney® cycling test chamber, TPS, White Deer, PA, USA) was applied 
to freeze-thaw the 500 mL solution. The step-wise program resulting in superimposable 
temperature-time profiles between the 500 mL and the 5 L containers is shown in Table 1.  
The specific solution temperature profile during freeze-thaw was monitored by seven 
temperature probes (type T thermocouples) to support the scale-down development. The 
thermocouples (Tc’s) were attached to data loggers (MicroDaq, SD-947-KIT, Contoocook, NH, 
USA) and placed at distinct regions within the bulk. Three Tc’s were inserted at the radial center 
of the solutions at different heights from the bottom to the top of the solution. Two Tc’s were 
placed at two opposite edges of the container at a middle height level. And, two Tc’s were placed 
at opposite corners of the container at a middle height level.  
Following the F/T cycles, the material at the end-point was sampled and the LDH quality 
attributes were assayed. In addition, potential freezing-perturbing conditions in each scale were 
extensively analyzed. 
 
5.4.4 Assessment of LDH quality attributes  
Post each freeze-thaw cycle in either 500 mL or 5 L container, a representative sample was 
withdrawn from the bulk and filtered through a 0.22 µm filter. The samples were analyzed for the 
protein concentration, percentage loss of LDH native tetrameric species, retention of LDH 
enzymatic activity, turbidity, pH, and subvisible particles formation.  
The turbidity was analyzed by an OD plate reader at 405 nm. The solution pH was 






Kowloon, Hong Kong). The LDH concentration was determined from the absorbance at 280 nm 
by a SoloVPE UV/Vis Spectrophotometer (C Technologies, Inc., Bridgewater, NJ, USA) using an 
extinction coefficient of 1.44 mL mg-1 cm-1 19. 
The activity of LDH was determined using an LDH activity kit (Sigma-Aldrich Co., St. 
Louis, MO, USA), where LDH catalyzes the reduction of NAD to NADH, which is detected by a 
colorimetric assay at 450 nm. The LDH enzymatic activity was determined in triplicates, 
normalized by the LDH concentration in each sample, and expressed as the remaining percentage 
(%) of activity relative to the initial values before freezing.  
Size exclusion chromatography (SEC) was used to determine the extent of LDH tetramer 
recovery post-F/T. Analyses were performed on an 1100 Agilent HPLC system coupled with 
Chemstation software®. Samples were separated on an SEC column (TSKgel™G3000SWXL, 7.8 
mm 30 cm, 5 µm; Tosoh Bioscience, San Francisco, CA, USA) which was maintained at 25 °C. 
The mobile phase was 100 mM phosphate buffer with 0.2 M NaCl (pH 7.0) delivered at 1.0 
mL/min. Elution was recorded on a diode array UV detector, and calculations performed based on 
220 nm chromatograms. Results were reported as the loss percent of LDH tetramer contents 
relative to the initial values before freezing.  
The concentration of subvisible particles in 1–100 µm size range was measured by a micro-
flow imaging system (MFI-5200, Protein Simple, San Jose, CA, USA) equipped with a 100 µm/1.6 
mm flow cell. The measurement involved flushing of the flow cell with a 0.22 mL sample, 
followed by imaging analysis of a 0.68 mL sample. Reported values are the average of two 
samples. 
 






Similar to the methodology described in Chapter 3, each frozen solution was axially cut 
into five or seven even layers (2.0 cm each) using a compound miter saw with a pre-cooled blade 
(TS1345L, Ryobi, Anderson, SC, USA). Each layer from the 500 mL bottle was subsequently 
divided into five even columns and, finally, each column was sliced into five even rows, resulting 
in 125 ice-cored cubes (2.0 cm x 1.5 cm x 1.5 cm). Whereas, each layer from the 5 L bottle was 
subsequently divided into 10 even columns and rows, resulting in 700 ice-cored cubes (2.0 cm x 
1.5 cm x 1.5 cm). Afterwards, 7 representative samples per layer were selected, resulting in 35 
samples per 500 mL container and 49 samples per 5 L container.  
The selected samples were individually thawed at room temperature and filtered through a 
0.22 µm filter before analyses. Ice-cored samples were analyzed for the percentage of loss in LDH 
tetramers and LDH enzymatic activity according to the methodology described in the previous 
section. Nevertheless, the protein concentration was determined from the absorbance at 595 nm 
applying a Bradford assay 20 (Coomassie Plus Bradford Assay Kit 23236, Thermo Scientific, 
Rockford, IL USA). 
 
5.4.5.1 Homogeneity score 
A homogeneity score (H-Score) was created and defined according to equation 1 to 
quantify the homogeneity of solute distribution post freezing. HS was calculated for LDH 
concentration in each bottle.   
𝐻𝑜𝑚𝑜𝑔𝑒𝑛𝑒𝑖𝑡𝑦 𝑆𝑐𝑜𝑟𝑒 = 1 − (
𝑀𝐴𝐷 (𝑋)
𝑀𝑒𝑑𝑖𝑎𝑛 (𝑋)
)                         Equation 1 
where X is the protein concentration measurement and MAD is the median absolute deviation 
around the median of the measurements as defined by equation 2. 






For perfectly homogenized system H-Score = 1; introduction of heterogeneity gradually decreases 
the H-Score to its minimum (H-Score = 0). 
 
5.4.6 Determination of ice surface area 
The role of the ice-aqueous interfacial area on LDH degradation was investigated by the 
determination of the ice surface area (SA) from Brunauer-Emmett-Teller (BET) surface area 
analysis of freeze-dried samples. 
The frozen bottles were sliced into representative samples from the center or periphery of 
the container. Periphery samples were composed of the frozen material close to the four edges and 
corners inside the square containers. The ice-cored samples from distinct regions within the bulk 
were dried in a LyoStar™ 3 (SP Scientific, Stone Ridge, NY, USA). Briefly, the frozen samples 
were loaded onto pre-cooled shelves at -40 °C. The same shelf temperature was held for 20 
minutes. For primary drying the shelf was heated at 0.5 °C/min to -33 °C and the chamber pressure 
was set at 100 mTorr. When the Pirani gauge reading converged with the capacitance manometer 
reading, the shelf temperature was raised to 40 °C at 0.1 °C/min and held for 5 h at the same 
chamber pressure setting. 
Specific SA analysis (measured SA divided by the weight of the freeze-dried powder, 
reported as m2/g) was carried out by the method of gas adsorption isotherm. The BET analyzer 
used was the Flowsorb II 2300 (Micromeritics Instrument Corporation, Norcross, GA, USA). 
Instrument calibration was performed with 100% Krypton gas, and a mixture of 0.1 mol% Krypton 
in Helium was used for sample analysis. The samples were prepared inside a glove bag to minimize 
moisture adsorption and degassed for 2 hours at 40˚C under the flow of the helium and krypton 






nitrogen to carry out a single-point analysis of Krypton adsorption onto the samples. Desorption 
followed by dipping the sample tube in a water bath at room temperature. The ice surface area 
(reported as m2/100 mL of solution) was calculated from the average SSA values of four 
independent measurements along with the standard deviations using Equation 3.  
𝐼𝑐𝑒 𝑠𝑢𝑟𝑓𝑎𝑐𝑒 𝑎𝑟𝑒𝑎 (
𝑚2
100 𝑚𝐿
) = 𝑆𝑆𝐴 (
𝑚2
𝑔
) 𝑥 % 𝑠𝑜𝑙𝑢𝑡𝑒 (
𝑔
100 𝑚𝐿
)              Equation 3 
 
5.5 RESULTS 
5.5.1 Achieving a scale-down model by superimposing freeze-thaw profiles 
Uncontrolled rate F/T processes developed at small scale are not linearly transferable to 
large scale, and vice-versa. As represented in Figure 1a, small volumes of solution (dashed black 
line for uncontrolled F/T of 500 mL solution) cannot directly represent large-scale systems (solid 
black line for the 5 L container). Due to the differences in the total thermal load and the heat and 
mass transfer distances between the two scales, the solution inside the 5 L bottle takes 
approximately double of the time to complete both freezing and thawing, compared to the 500 mL 
solution processed at the same conditions.  
The solution fill volume inside the 500 mL square polycarbonate bottles was maximized 
(100 % fill) to achieve a similar surface area to volume ratio (SA/V) as that obtained at the 5 L 
scale. Although, the SA/V ratio was still quite distinct: 0.73 cm-1 for the 500 mL bottle compared 
to 0.42 cm-1 for the 5 L container. The designed freeze-thaw scale down method at conditions 
mimicking the stresses expected at large-scale manufacturing required the consideration of 
multiple factors beyond similar SA/V, such as container-closure material, size of containers, fill 
volume, and superimposable freeze-thaw profiles. 






characterized at a large-scale: 5 L square polycarbonate bottles filled with 3.5 L of the protein 
solution and F/T at uncontrolled rates. The resulting product temperature profiles at the 5 L scale 
were then used to develop the freeze-thaw cycles at the 500 mL scale, using a controlled rate 
freezer (CRF) system (solid red line in Figure 1a). 
The chamber set-point temperature for the scale-down unit was programmed (Table 1) in 
such a way that the product temperature profiles observed at multiple points in the small-scale 
bottle were superimposed over the ones seen at large scale. The controlled rate F/T methodology 
resulted in similar product temperature profiles between the 3.5 L and 500 mL of the LDH solution. 
Moreover, the step-wise program was optimized to guarantee not only superimposable profiles at 
the geometrical center of the solutions (the last point to freeze-and-thaw, Figure 1a) but also at 
varying heights of the solution (Figure 1b), at opposite edge positions inside the containers (Figure 
1c), and at the corner regions of the square bottles geometry (data not shown). 
 
5.5.2 Impact of freeze-thaw at distinct scales on protein quality 
The impact of the freeze-thaw conditions on LDH quality attributes was assessed in both 
small- and large-scale containers. Figure 2 shows the relative change in LDH enzymatic activity 
and quaternary tetrameric structures post a single freeze-thaw cycle. Uncontrolled rate freeze-thaw 
was carried out in both 500 mL and 5 L containers. In this case, the bottles were frozen at -30 °C 
in a regular freezer and thawed at room temperature. Additionally, the 500 mL solution was freeze-
thaw using a controlled rate methodology. 
Uncontrolled freeze-thaw of the same solution but at either 500 mL or 5 L scales resulted 
in distinct LDH activity and loss of tetramers. Freeze-thaw processing of the smaller volume of 






quality attributes (Figure 2); the LDH activity was 96%, and the loss of tetramers was only 0.25% 
compared to the initial solution. On the other hand, freeze-thaw processing at the 5 L scale resulted 
in a remarkable loss of LDH activity (only 82% of the initial enzyme activity) accompanied by 
1.2% loss of LDH tetramers. Interestingly, when the controlled-rate methodology was applied to 
the 500 mL solution, no difference was noted in LDH quality attributes between the two scales.  
The formation of subvisible particles was also investigated post freeze-thaw as a factor of 
the volume scale (Figure 3). The protein solution was analyzed by microflow-imaging before (T0) 
and after (FTx1) the freeze-thaw cycle. Both the solution volume and the freeze-thaw methodology 
(uncontrolled and controlled-rate process) impacted on the subvisible particle counts. 
Uncontrolled freeze-thaw resulted in distinct particulates concentration for the 500 mL and 5 L 
solutions. The concentration of particles equal or above 10 µm was two times higher in the samples 
from the 5 L container compared to the 500 mL container, and six times higher for particles equal 
or above 25 µm. The higher subvisible particle concentration observed post 5 L freeze-thaw was 
reproduced in the 500 mL scale applying the controlled-rate methodology. 
Additional LDH quality attributes were evaluated before and after the freeze-thaw cycles, 
as shown in Table 2. Although there was a 4-fold increase in turbidity for the 5 L regular freezing 
and 500 mL controlled-rate freezing compared to the 500 mL regular freezing condition, no 
difference was noted in the solution pH or LDH concentration recovery among the conditions 
studied.  
The stepwise program developed for the controlled-rate chamber (Table 1) resulted in 
superimposable temperature-time profiles between 500 mL and 5 L containers filled with 0.1 
mg/mL LDH solution in histidine buffer. Such experimental approach also led to equivalency in 






methodology can thus be applied to characterize bulk-scale freeze-thaw processes and to 
understand the impact of process variables on protein stability.  
 
5.5.3 Magnitude of freezing-induced stresses at distinct volume scales 
Once equivalent bulk-averaged protein quality attributes were achieved at the two volume 
scales, the magnitude of the freezing-induced stresses potentially fostering protein instability was 
also mechanistically evaluated. In the present study, we investigated the relative contribution of 
solutes freeze-concentration and ice surface area to the bulk-averaged protein stability. 
The frozen solutions at -30 °C inside the 500 mL and 5 L square bottles were evenly cut 
into ice cubes (2 cm x 1.5 cm x 1.5 cm in dimension). The LDH concentration was measured in 
pre-determined ice-cored samples from the bulk to obtain a 3D profile of the protein distribution 
(Figure 4). The distribution of the protein concentration in the frozen mass was highly dependent 
on the freezing profile. Faster freezing of the 500 mL solution at uncontrolled condition resulted 
in a more homogeneous distribution of the protein (Figure 4a), in this case, the protein 
concentration varied from 57% to 167%, and the majority of the ice-cored samples from distinct 
bulk regions maintained unaltered LDH concentration post-freezing. Whereas, after the slower 
uncontrolled 5 L freezing the protein concentration varied extensively, from 5% to 331% (Figure 
4b). Furthermore, the controlled-rate freezing of the 500 mL solution better reproduced the 
dispersion in LDH concentration within the frozen bulk observed at the 5 L scale, varying from 
4% to 302% (Figure 4c) and also resulted in similar homogeneity score (Table 3).   
The calculated homogeneity score based on the ice-cored samples corroborated with the 
observation from the 3D scatterplots: higher freezing rate at the 500 mL regular freezing condition 






whereas a longer freezing process accentuated the degree of solutes dispersion post freezing (H-
Score equal to 0.55 and 0.45 for the 5 L regular freezing and 500 mL controlled rate freezing, 
respectively). 
Figure 5 shows the average change in LDH activity and loss of tetramers at the ice-cored 
samples for each frozen container. The LDH activity varied from 83% to 136% within the 500 mL 
container post regular freezing. Whereas, post 5 L freezing the protein activity varied extensively, 
from 32% to 118%, similar to the variation from 28% to 132% observed after controlled-rate 
freezing of the 500 mL solution (Figure 5a). Similarly, the change in loss of LDH tetramers ranged 
from 0.24% to 10.5% post 5 L freezing and from 0.34% to 8.6% post 500 mL controlled-rate 
freezing; which significantly differed from the narrowed variation from 0.04% to 3.08% observed 
post regular freezing of the 500 mL solution (Figure 5b). 
The average LDH activity for the 500 mL regular freezing condition remained closer to the 
initial enzyme activity before freezing (104%), and there was only a slight increase in the average 
loss of LDH tetramers of 1.1%. These findings were significantly different at 95 % confidence 
interval from both 5 L regular freezing and 500 mL controlled-rate conditions, which resulted in 
72 to 79% averaged LDH activity and 2.8% loss of LDH tetramers on average.  
Specific surface area analysis was carried out to determine the role of the ice-aqueous 
interface on LDH quality attributes at different volume scales. Each frozen protein solution was 
dissected into representative samples from the center or periphery regions of the 5 L and 500 mL 
bottles. The specific surface area was obtained from BET surface area analysis of the freeze-dried 
samples, which was multiplied by the solutes content in each sample to obtain the ice surface area 
(Figure 6). 






the higher freezing rate of about 0.10 °C/min, compared to the 0.04 °C/min rate observed at both 
5 L regular freezing and 500 mL controlled-rate conditions. As expected, faster freezing resulted 
in greater ice surface area at samples measured from both center and periphery regions inside the 
500 mL container post regular freezing. A decrease in the ice surface area from 0.76 ± 0.02 to 0.31 
± 0.02 m2/100mL was observed when the center samples were exposed to both the slower freezing 
rates. Moreover, the distance of the sample from the actively cooled surface of the container had 
an impact on the ice surface area developed. Periphery samples, closer to the container wall, 
exhibited a smaller ice surface area compared to ice-cored samples from the center of the bottle. 
Overall, controlled rate freezing of the 500 mL solution better reproduced the ice surface area 
observed at the 5 L frozen bulk measured in freeze-dried samples withdrawn from both the center 
and periphery regions inside the containers.  
 
5.6 DISCUSSION 
The freeze-thaw conditions that prevail in the large-scale unit can be easily reproduced by 
keeping the same freezing path length as that at large-scale. In that way, the freezer temperature is 
the only variable that determines the rate of freezing, because of the predominantly one-
dimensional heat conduction 3. This strategy inspired the design of the Sartorius Stedim bag 
systems. Most of the research on scale-down process was done in bags and using the programmable 
temperature control system supplied by Sartorius Stedim 9,21,22. Following a similar strategy, 
Shamlou et al. 3 designed a rectangular container resulting in the same heat transfer path length 
between a small-scale (30 mL volume) and a larger 2 L stainless steel container. In commercially 
available plastic containers, however, the heat transfer path length changes as the bottle dimensions 






The field of single-use bioprocess technologies is rapidly expanding. With that, there is a 
recent shift from traditional stainless-steel containers for freezing protein solutions to disposable 
containers, such as plastic bottles. Freeze-thaw, when coupled with single-use containers, provides 
some advantages over stainless-steel containers, including reduction in capital requirements, 
elimination of clean-in-place and sterilization-in-place utilities, and shortening of the process 
turnaround time. Single-use systems also mitigate the risks of cross-contamination, particularly in 
multiple product facilities. Thus, the present study focused on the development of a scale-down 
technology to support the gradual trend in the industry towards the use of plastic bottles. In such 
containers, the freeze-thaw process is not linearly scalable. Because of this, a new scale-down 
methodology was investigated to ensure scalability between 500 mL and 5 L square polycarbonate 
containers. First, the temperature-time profiles of a 5 L large-scale system under uncontrolled 
freeze-thaw conditions were generated. These profiles were used to simulate similar conditions for 
the 500 mL scale, using a controlled rate system. The step-wise program (Table 1) developed for 
the controlled-rate unit resulted in superimposable product temperature profiles between the two 
bottle scales (Figure 1).  
Freeze-thaw of larger volumes and larger dimensions involves factors that are often 
ignored in smaller-scale studies. The ice crystals first form and grow closer to the surfaces in large 
containers, from which heat is being removed. The freezing rate is generally lower than at small-
scale systems, and the rate of freezing will progressively decrease as the thickness of the ice layer 
increases. Thus, large-scale freezing inherently leads to considerable temperature gradients and 
non-uniform onset of crystallization 14. For this reason, no single point of measurement can 
properly represent the freezing process at large-scale. Despite of that, previous scale-down studies 






temperature probe was fixed at the last point to freeze inside the solution to establish the 
equivalency in temperature-time profiles between scales 3,12,21,22. To fill this literature gap, the 
present study monitored the temperature of several positions inside the solutions upon freeze-thaw. 
The multiple set-point profile adjustment on the scale-down unit was done carefully to ensure the 
reproducibility of the moving ice front. As shown in Figures 1a and 1b, there was a good agreement 
between the 500 mL and 5 L scales regarding the overall freeze-thaw. For example, our results 
demonstrated similar freezing progression in both scales; freezing started at positions close to the 
surface of the container and progressed towards the geometrical center of the solution (last point 
to freeze). 
Following the freeze-thaw process, the LDH quality attributes were assayed in both volume 
scales. The small-scale model successfully reproduced the impact of the large-scale freeze-thaw 
rates on the loss of LDH enzymatic activity, loss of LDH tetramers, and formation of subvisible 
particles (Figures 2 and 3). These findings might be explained by the effectiveness of the small-
scale model in reproducing the freeze-thaw progression observed at the large-scale. Such an 
equivalent process profile exposed the protein molecules to the same residence time in a low-
viscosity fluid state. The residence time in a freeze-concentrated but relatively fluid system is 
recognized as a predominant factor in drug substance destabilization during freeze-thaw 23. 
Therefore, the superimposable product temperature profiles between 500 mL and 5 L containers 
led to comparable LDH quality attributes post freeze-thaw.  
 
5.6.1 Influence of the volume scale on the magnitude of freezing-induced stresses  
A number of authors have recognized that a scale-down model that reflects the product 






processed at manufacturing-scale 9,24. It is also clear that protein quality attributes are influenced 
by the magnitude of destabilizing stresses arising during freeze-thaw. However, no attempt has 
been made to characterize the freeze-thaw scale-down models based on the underlying 
destabilization mechanisms emerging during the process.  
Destabilization of proteins during freezing can be induced by the formation of ice-liquid 
interfaces, freeze-concentration of solutes, and cold denaturation 25,26. Previous studies have 
emphasized, however, the negligible contribution of cold denaturation to the overall LDH freeze 
denaturation 27,28. Thus, the developed scale-down model was characterized based on the 
magnitude of ice surface area and freeze-concentration of solutes.   
The heat transfer distances encountered in large-scale systems often induce non-uniform 
ice nucleation and crystal growth. Consequently, solutes are progressively transported toward 
later-freezing regions by diffusion and natural convection 29. The redistribution of solutes upon ice 
crystallization is known as macroscopic freeze-concentration. 
The extent of the protein redistribution within the frozen bottle was highly dependent on 
the volume being processed, and thus, on the freezing rate. Observations from the 3D scatterplots 
(Figure 4) and the homogeneity scores (Table 3) revealed a more evenly distribution of the LDH 
concentration post uncontrolled freezing of the 500 mL solution. This experimental condition 
correlated to the higher freezing rate observed (0.10 °C/min). More homogeneous protein 
distribution (H-Score = 0.87) also correlated with better retention of the LDH quality attributes 
post freeze-thaw (Figure 5). Furthermore, the scale-down approach resulted in several equivalent 
parameters between the 5 L uncontrolled freezing and 500 mL controlled-rate freezing: lower 
freezing rate (0.04 °C/min), heterogeneous LDH distribution within the frozen bottles (H-Score = 






significant loss of LDH tetramers (2.8 ± 0.1%; average from ice-cored samples) post freeze-thaw. 
The morphology and surface area of ice crystals are governed by the ice nucleation 
temperature, solution composition, and the freezing rate 28,30,31. Fast freezing usually results in a 
high degree of supercooling and therefore, a large number of smaller ice crystals, with a large ice-
aqueous interfacial area 32. Literature suggests that large ice-aqueous interfacial area imparts 
greater stress, leading to greater protein damage compared to slow freezing 30,33. Bhatnagar et al. 
28 directly correlated LDH degradation to the extent of the ice-aqueous interfacial area developed 
on freezing. 
The specific surface area reflects the pore size of a freeze-dried material and, assuming no 
collapse during drying, is a template of the ice crystals formed during freezing. Thus, surface area 
measurements can indicate the size and morphology of the formed ice crystals 31,34. The results 
shown in Figure 6 demonstrated that the ice surface area strongly depended on the volume of the 
solution, freezing methodology, and the position of the sample (frozen solution cored from the 
center or the periphery of the bottle). The ice-cored samples from the 500 mL bottle post 
uncontrolled freezing exhibited in average 3.5-fold higher ice surface area compared both 5 L 
uncontrolled freezing and 500 mL controlled-rate freezing. Moreover, the scale-down approach 
effectively reproduced the ice surface area measured post large-scale freezing. 
The results revealed that samples from the center of the bottles had a higher ice surface 
area, compared to samples from the periphery of the frozen bulk. Higher ice surface area is 
commonly attributed to higher velocities of the freezing front 32. This is consistent with what has 
been found by Rodrigues et al. 11. In their study, the linear ice front velocity increased as the ice 
front propagated toward the center of the container upon freezing. 






state that the equivalency in freeze-thaw profiles resulted in similar stresses arising during the 
process, which resulted in equivalent protein quality attributes post freeze-thaw in either 500 mL 
or 5 L scales. Regulatory guidance states that a scientifically justified model can be used to 
extrapolate operating conditions across multiple scales and equipment and can enable a prediction 
of quality 35. Therefore, this new scale-down model can be leveraged to set process parameters for 
the manufacturing-scale and to verify formulation robustness to freeze-thaw stresses, while 
alleviating the material requirements of large-scale studies.  
 
5.7 CONCLUSIONS 
A new method of freeze-thaw was developed based on equivalency of product temperature-
time profile of LDH solutions in 500 mL and 5 L rectangular polycarbonate bottles. In contrast to 
earlier studies, scalability was defined in terms of equivalency of temperature-time profile for the 
protein solution at several positions inside the container. 
For the first time, this study has thoroughly characterized a freeze-thaw scale-down model 
based on the magnitude of destabilizing stresses. Importantly, our results provided evidence that 
the extent of freezing-induced stresses is impacted by the volume scale (500 mL or 5 L), during 
uncontrolled freeze-thaw. The developed scale-down methodology reproduced not only the 
temperature-time profiles but also the stressful conditions observed in the large-scale unit. 
Nevertheless, by matching the stresses fostering protein degradation in both scales, the overall 
protein quality attributes were also equivalent. In addition to its reliable scalability, this new 
approach can guide scale-down method development for uncontrolled freeze-thaw unit operations, 
so far lacking in the scientific literature.  






characterizing a new scale-down methodology. This promising methodology seems suitable to 
identify freeze-thaw process conditions for larger manufacturing-scales, assess formulation 
robustness to potential freeze-thaw stresses, and to support recommendations for manufacturing, 
storage, and handling of biopharmaceutical solutions subject to freeze-thaw unit operations. 
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BET – Brunauer-Emmett-Teller  
CQA – critical quality attribute 
CRF – controlled rate freezer 
F/T – freeze-thaw 
H-Score – homogeneity score 
LDH – L-lactate dehydrogenase 
MAD – median absolute deviation 
MFI – Micro-Flow Imaging 
NAD – nicotinamide adenine dinucleotide 
NADH – reduced nicotinamide adenine dinucleotide 
RF – regular freezer (uncontrolled rate)  
SA – surface area  
SEC – size exclusion chromatography 


















Table 1. The step-wise program applied to freeze-thaw a 500 mL solution which resulted in 
superimposable temperature profiles with a 5 L solution under uncontrolled freeze-thaw process. 
Step number Step type Temperature ( °C) Time (min) 
1 set point -1 0 
2 ramp -1.5 120 
3 ramp -20 20 
4 ramp -4 15 
5 hold -4 410 
6 ramp -17 320 
7 ramp -26 100 
8 ramp -31 270 
9 hold -31 175 
10 ramp -2 75 
11 ramp 0.5 30 
12 hold 0.5 150 
13 ramp 4 60 
14 hold 4 60 
15 ramp 6 60 
16 hold 6 120 
17 ramp 8 60 
18 hold 8 390 
19 ramp 11 30 
20 ramp 11 5 
21 hold 12.5 30 




















Table 2. Characterization of LDH quality attributes post freeze-thaw at distinct conditions 
Volume of solution Freezing methodology 
Turbidity (increase in 
OD at 405 nm) 
pH % LDH recovery 
500 mL Regular freezing 0.0003 (0.0004) 5.82 (0.01) 100.00 (0.02) 
5 L Regular freezing 0.0014 (0.0004) 5.81 (0.01) 97.96 (1.36) 

















































Table 3. Homogeneity score (H-Score) for the LDH solution frozen at distinct volumes and rates. 
Volume of protein solution Freezing methodology LDH concentration H-Score 
500 mL Regular freezing 0.87 
5 L Regular freezing 0.55 




















































Figure 1. Product temperature profiles obtained for a LDH solution during freezing and thawing: 
(a) comparison of geometrical center temperature under regular freezing (RF) and controlled rate 
freezing (CRF) in either 500 mL or 5 L containers; (b) temperature profile at center middle and 
center top positions inside the 500 mL CRF and 5 L RF; (c) temperature profile at edge right and 











Figure 2. Retention of LDH enzymatic activity and loss of LDH tetramers post regular 
(uncontrolled) freezing at -30 °C and static thawing at room temperature in 500 mL and 5 L 



















Figure 3. Sub-visible particles concentration at the (a) 1-2 µm, (b) 2-10 µm, (c) ≥10 µm, and (d) 
≥25 µm particle size ranges. Measurements performed before (T0) and after regular (uncontrolled) 
freezing at -30 °C and static thawing at room temperature in 500 mL and 5 L containers (n=2) or 




















Figure 4. Macroscopic freeze-concentration profile of LDH concentration in (a) 500 mL solution 
post uncontrolled freezing at -30 °C, (b) 5 L solution post uncontrolled freezing at -30 °C, and (c) 
500 mL solution post-controlled freezing. Darker red bubbles indicate bulk regions with higher 
LDH concentration, whereas light bubbles indicate decreased LDH concentration compared to the 

























Figure 5. Tukey-Kramer HSD comparisons for all means of either 35 or 49 ice-cored samples from 
the 500 mL and 5 L containers, respectively. The means are significantly different at 95% 
confidence interval between 5 L regular freezing (RF) and 500 mL RF; and there is no significant 
difference between the 5 L RF and 500 mL controlled rate freezing (CRF) groups for both (a) % 
























Figure 6. Ice surface area measured post uncontrolled freezing (RF) at -30 °C of 500 mL or 5 L 
solution and post controlled rate freezing (CRF) of 500 mL solution. Measurements performed at 
freeze-dried samples withdrawn from the center or periphery regions of the containers. The 




























































Chapter 2 characterized the F/T process at large-scale (1 L polycarbonate bottles) and 
revealed the impact of several F/T process parameters on quality attributes of a model protein 
solution, 10 µg/mL L-lactate dehydrogenase (LDH) in 20 mM histidine buffer, pH 7.0. 
A design of experiments approach was applied to evaluate the following process 
parameters: distance among multiple containers, fill volume, freezer set temperature above and 
below the glass transition temperature (Tg’), and a novel forced air-flow method. We observed 
variable F/T rates and ice front velocities at different regions within the 1 L bottles. Moreover, the 
analysis from 46 experimental runs indicated over 4-fold increase in the freezing rate when the set 
freezer temperature was lowered from -20 °C to -80 °C, and a two-fold increase in the thawing 
rate by the forced-air flow methodology.  
The retention of both LDH activity and LDH tetramers varied broadly with the F/T 
processing conditions, however, the parameters of both freezing and thawing steps had comparable 
effect. The design space resulting in adequate LDH quality attributes post-F/T was comprised of 
(a) freezing temperature between -60 °C to -76 °C, (b) solution fill volume from 65% to 82% v/v, 
(c) distance of 7.6 cm to 9.5 cm among nine bottles in a 3x3 array (d) forced air-flow at 98 fpm 
during thawing. 
In summary, the DoE-based systematic analysis increased F/T process understanding at 
large-scale, identified critical F/T process parameters, and confirmed the feasibility of a faster 
freezing rate and forced-air thawing procedure to enhance the stability of LDH solutions exposed 
to bulk F/T unit operations.  
 
From the 46 F/T DoE runs performed in Chapter 2, we observed that F/T at faster rates 






resulted from the relative magnitude of stresses arising during freezing, which are capable of 
denaturing proteins. Therefore, Chapter 3 aimed to better understand the underlying mechanisms 
of protein denaturation post large-scale F/T process. We characterized the relative contributions 
of freezing-induced stresses, such as the ice surface area, extent of solutes freeze-concentration, 
and residence time in the low-viscosity fluid state to the protein instability post-F/T cycles.   
This study represents the first time that ice surface area was measured in dried samples 
from large-volume protein solutions. The results demonstrated that the surface area of the ice 
formed strongly depended on the freezing rate and the position of the sample inside the 1 L 
containers (center versus edge samples). The ice-cored samples from the solution frozen at the 
higher freezing rate of 0.215 °C/min exhibited close to 5-fold higher ice surface area compared to 
the samples frozen at 0.031 °C/min. Thus, the examined ice surface area did not explain the 
enhanced protein stability at higher freezing rates. Instead, our results correlated the LDH 
degradation during the large-scale F/T processing to the degree of solutes redistribution during 
freezing. Overall, the LDH quality attributes were better maintained at faster freezing rate, which 
led to more homogeneous protein distribution throughout the frozen bottle.  
The residence time of the protein molecules in the low-to-moderate viscous state after ice 
formation was implicated as the predominant factor in protein destabilization during freezing. 
During this period, the protein was exposed to freezing-induced stresses, among which the 
extensive solutes freeze-concentration was identified as the primary cause for protein degradation 
in large-scale F/T process. 
Novel methodologies providing a more fundamental understanding of two mechanisms for 
the degradation of proteins that occurs during freezing have been provided by this dissertation 






the ice surface area, the morphology of the ice crystals, and the degree of macroscopic freeze-
concentration of solutes that occur during bulk freezing of solutions.  
 
Chapter 4 systematically evaluated the impact of the freezing rate on heterogeneous 
distribution of solutes post-freezing. A novel methodology was designed to measure the spatial 3D 
distribution of solutes (i.e., LDH, sucrose, and phosphate buffer) and to quantify the protein quality 
attributes at different regions in the frozen volume.  
Bulk freezing in 1 L bottles was found to generate extensive solutes redistribution, which 
was further verified to negatively affect the LDH quality attributes. In general, the solutes 
concentrated towards the center and bottom of the bottles during freezing, leaving the peripheral 
and top regions with significantly fewer solutes. Higher LDH enzymatic activity was retained at 
the center of one of the two bottom layers, while the lowest activity was found along the four edges 
of the bottle. 
Moreover, blast freezing resulted in a higher freezing rate compared to the conventional, 
stagnant-air freezer and achieved higher homogeneity in solute distribution within 1 L bottles. 
Higher freezing rates also correlated with significant retention of LDH activity and tetrameric 
native structures. 
Formulations containing sucrose showed enhanced protein stability after freezing. 
However, our results also suggested the occurrence of amorphous phase separation of the 
formulation components; sucrose was depleted to a greater extent at the peripheral regions of the 
containers. Phase separation compromised the stabilizing effect of sucrose and had negative 
implications for the LDH stability. 






inside the bottle, and presence of sucrose all have significant impact on LDH stability. Significant 
retention of LDH initial activity was observed after blast freezing and for the samples closer to the 
center-bottom regions within the frozen volume. 
A rapidly advancing ice front is critical to entrap solute molecules uniformly and to prevent 
prolonged freeze-concentration stress in the protein solution. This study showed that a faster 
freezing rate resulted in greater homogeneity, maintained higher LDH activity, and reduced the 
LDH tetramer dissociation during freezing. Thus, faster freezing, which can be achieved by blast 
freezers, not only can reduce manufacturing time but can also help to maintain the drug product 
quality.  
 
Chapter 5 investigated a new scale-down methodology for uncontrolled freeze-thaw 
which ensured scalability between 500 mL and 5 L square polycarbonate containers filled with 
LDH solution. The strategy to develop the scale-down method included: (i) similarity between 
container material (polycarbonate) and geometry (square), (ii) similarity between the freezer set 
temperature (-30 °C) and thawing end-point (18 °C), (iii) similarity between the surface area to 
volume ratio by maximizing the solution fill volume in the small-scale bottle, and (iv) similarity 
between the product temperature-time profiles across the two scales. The former strategy was 
achieved by a stepwise program developed using a controlled-temperature chamber. Moreover, 
the equivalency of product temperature-time profile was demonstrated at several positions inside 
the 500 mL and 5 L containers; not only at the last point to freeze-or-thaw. 
Following the freeze-thaw process, the LDH quality attributes were assayed in both volume 
scales. The small-scale model successfully reproduced the impact of the large-scale freeze-thaw 






particles. For the first time, the freeze-thaw scale-down model was thoroughly characterized based 
on the magnitude of destabilizing stresses to proteins arising during the process. Our findings 
indicated a similar extent of the protein macroscopic freeze-concentration and equivalent ice 
surface area post-freezing in the large-scale bottle and scale-down system.  
The developed scale-down method of a single 5 L container is not directly applicable but 
is expected to be extrapolatable to more practical manufacturing conditions at full or partial loading 
during freeze-thaw processes. Future work would help to determine whether the findings in 
Chapter 5 can be extrapolated to larger sets of containers subjected to freeze-thaw. 
Overall, the scale-down method effectively reproduced the large-scale freeze-thaw 
process, through equivalency in temperature-time profiles, protein quality attributes, and freezing-
induced stresses. Implementation of this methodology could, therefore, represent an advantageous 
alternative to define adequate freeze-thaw parameters and to assess formulation robustness to 
potential freeze-thaw stresses in a more cost-effective and less time-consuming manner. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
